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Detecting cancer early is recognized as one of the most effective strategies to im-
prove prognosis and chances of survival. However, while screening and diagnostic
technologies are advancing, their effectiveness relies on a quantitative understand-
ing of the complex biological processes underlying the development of a tumor.
Suitable theoretical frameworks to investigate and describe these processes are
often provided by mathematical models, whose results can then be reinterpreted
in the context of cancer evolution.
In this thesis we consider two mathematical descriptions for the growth of tumors
and related cellular populations. The first one leads to estimates for the first time
that a metastasis generated by a primary lesion becomes detectable. The second
presents instead an abstract representation for an emerging and promising type
of screening tests called liquid biopsies. Quantitative features of these models
are also compared with relevant clinical data. Furthermore, both approaches are




Cancer is among the leading causes of death worldwide. While primary tumors
are often treated effectively, they can spawn secondary cancers called metastases
which dramatically decrease chances of survival. In order to develop success-
ful therapies, it is thus crucial to estimate the time until metastases appearance
and improve our ability to detect primary tumors before metastases are gener-
ated. The estimation of the time to cancer recurrence depends on the dynamics
of tumor growth and metastases seeding. For early detection, promising results
have recently been obtained with liquid biopsies, id est the analysis of specific
biomarker levels in blood samples. This thesis investigates these problems by
studying mathematical models of cancer evolution and liquid biopsies based on
the theory of branching processes.
Firstly, we consider first passage times to a given size in branching birth-death
processes. We derive their probability distribution and first moments conditioned
on non-extinction, comparing the results obtained for supercritical, critical and
subcritical processes. Such results for hitting times are presented both in exact
form and in their asymptotic limit for large sizes. In this limit we show that their
probability distribution asymptotically converges to extreme value types.
Second, we present a semi-stochastic model of cancer recurrence. The primary
tumor is described by a deterministically growing population of cells initiating
metastases at a rate proportional to its size. Each metastasis is then modelled
by a branching birth-death process with the same net growth rate. In this frame-
work we discuss several features of the time to cancer relapse, defined as the first
time that any metastasis reaches a given detectable size. We apply this model
to different cancer types and compare its predictions with data collected from
clinical literature.
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Third, we present a multi-type branching process model of biomarker shed-
ding. We focus on the case of circulating tumor DNA fragments shed in the
bloodstream by both cancerous and healthy cells. We model the population of
tumor cells as a supercritical branching birth-death process and take the healthy
cells population to be constant in size. As DNA fragments cannot reproduce or
divide, their amount is described by a pure death process with immigration. By
applying this model, we provide quantitative estimates for the number of circu-
lating tumor DNA fragments detectable in a blood sample, conditioned on the
primary tumor size. Comparing our estimates with clinical observations we then
discuss the potential of liquid biopsies for early cancer detection.
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Early detection of cancer leads to higher chances of survival and, in general,
better prognosis. However, modern screening techniques are not yet capable of
reliably diagnosing a tumor before the appearance of symptoms or the forma-
tion of metastases [169]. Similarly, available estimates for the time to cancer
recurrence still lack the required accuracy [189]. This thesis investigates these
limitations by studying stochastic models of cancer evolution. In particular, the
aim of this work is to develop mathematical tools that can help improve detec-
tion strategies for primary and secondary tumors. Our models are based on the
theory of branching processes and birth-death processes, and are analyzed both
qualitatively - by highlighting the mathematical features of the model - and quan-
titatively - by comparing model estimates with relevant clinical data.
Cancer evolution is an extremely complex biological process that is influ-
enced by a multitude of factors. For example, the course of the disease varies
widely across patients with different age, sex, lifestyle, genetic heritage or be-
tween tumors of different histological type, stage, aggressiveness. For this reason,
cancer research focusses both on studying newly discovered aspects of tumor de-
velopment and on improving our understanding of known cancer evolutionary
dynamics. In line with these efforts, our work addresses topics related to cancer
detection by presenting two models: the first is concerned with the long-studied
problem of estimating the time to cancer recurrence, while the second discusses
the potential for early detection of recently developed screening techniques based
on liquid biopsies.
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The first models pertaining the study of cancer considered the volume growth
of a tumor over time and trace back to the 1920s [16]. Since then the number
of mathematical applications to cancer research has increased enormously, pro-
viding insightful theoretical descriptions for several traits of tumor evolution, for
example tumorigenesis [196], cancer growth [16], metastasis formation [172], drug
resistance [114], intra-tumor heterogeneity [54] and many others. For historical
notes and reviews on some of the most important and recent contributions in this
field see e.g. [16, 11, 23].
In particular, in order to account for and characterize some of the variabilities
intrinsic to cancer development, a growing number of stochastic models have been
proposed, starting from the pioneering work of Armitage and Doll on carcinogen-
esis [17, 18]. In this context, a framework that has found many applications in
cancer modelling is based on the so-called Luria-Delbrück experiment. In their
Nobel prize winning work [127], Max Delbrück and Salvador Luria developed a
model to study the emergence of subpopulations resistant to a toxin in a bacterial
colony. They hypothesized that these subpopulations are initiated stochastically
by the original bacteria through mutations at reproduction, and modelled the
growth of both the original and mutant populations as deterministic exponential
functions. Several generalizations of their model were later introduced to include
stochastic growth of one or both populations (see [221, 37] for a review).
Our description of the time to cancer relapse is based on one of the semi-
stochastic generalizations (that is on the assumption of a deterministic seeding
intensity and a stochastic mutant growth) and it is presented in Chapter 3 of this
thesis. More precisely, we model a primary tumor growth as a specified function
of time, which stochastically initiates distant metastases. The evolution of each
of these metastases is then represented by a branching birth-death process with
positive net growth rate. Within this model we focus on the first time that any
of the initiated metastases becomes detectable, which we define as the relapse of
the disease. We also infer the model parameters for different cancer types, and
analyze the corresponding predictions for several quantities of clinical interest.
Our model can thus be employed to compute estimates for these quantities, as
well as to gain insight into the dynamics of metastasis formation and growth.
Both these quantitative and qualitative results can assist clinical practice, for
example by informing on the expected time to relapse of the disease if a patient
has no visible metastases at presentation, or on the effects of a delay in the time
of primary tumor surgical resection.
2
In the model above, the derivation of the probability distribution for the time
to cancer recurrence relies on results for hitting times to a certain size in branch-
ing birth-death processes. For this reason, in this thesis we first discuss the
distributions of these times, which are the main subject of Chapter 2. Such dis-
tributions spawn from a broad mathematical literature that highlights non-trivial
relationships between their exact form and special families of orthogonal polyno-
mials and between their asymptotic limit for large sizes and extreme value theory.
An intuitive prediction of our model for the time to cancer relapse is that the
earlier a primary tumor is detected and treated, the smaller are the chances of
developing metastases. Driven by this observation, we then started to investigate
screening methods for the early detection of cancer. Metastases form as cancer
cells disseminate from the primary tumor and succeed to establish a secondary
lesion in the surrounding tissue or elsewhere. In general, tumors are known to
release different biological products in the circulating system. Some of these sub-
stances, or biomarkers, can thus be searched for in blood samples from patients
and their analysis might in turn provide information on the tumor they were
shed by. Similar blood tests, called liquid biopsies, offer several advantages in
comparison to other screening techniques, but their potential and limitations -
especially for early cancer detection - still need to be entirely evaluated.
In this context, we propose a fully stochastic model of biomarker shedding. We
describe a population of cancerous cells as a supercritical branching birth-death
process which releases biomarker molecules at a given rate. Overall, the biomarker
is thus shed in the bloodstream at a stochastically varying rate. Each of the shed
molecules is then modelled by a branching pure death process. Some biomarkers
can be simultaneously released by a population of non-malignant cells, for exam-
ple by a benign lesion. We include this factor in our model, and assume the size
of the healthy population to stay constant over time. Overall, the biomarker is
thus shed in the bloodstream at a stochastically varying rate from cancer cells
and at a constant rate from healthy cells. In Chapter 4 of this thesis we apply
this framework to circulating tumor DNA and quantify the dependence between
tumor size and biomarker level. These results are then employed to assess the
potential of liquid biopsies as screening tests in clinical practice.
As highlighted throughout this introduction, our models are based on similar
settings where the evolution of biological populations is described by branching
birth-death processes. Many biologically relevant questions arising in our anal-
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ysis can be answered in terms of specific properties of these processes, and in
particular by characterizing the time taken by the modelled population to reach
a given number of cells. These standard and non-standard features represent
the main tools for our investigation and will thus be discussed separately before
introducing the two applied models.
With these motivations in mind, we now provide a short outline of this thesis.
1.1.1 Thesis outline
The rest of this thesis is organized as follows. In the remainder of this section
we provide a basic introduction to the main mathematical tools employed in our
work. Specifically, Section 1.2.1 presents classical notions related to branching
birth-death processes - with and without immigration - and about the inver-
sion of probability generating functions. In Section 1.2.2 we discuss fundamen-
tal concepts of extreme value theory, while Section 1.2.3 briefly introduces non-
homogeneous Poisson processes and Cox processes.
In Chapter 2 we define hitting times to a given state in branching birth-death
processes and derive their probability distributions. We discuss separately the
cases of supercritical, critical and subcritical processes, and derive both exact
distributions and their asymptotic limit for large sizes.
Chapter 3 is about our model of metastasis formation and growth. Based on a
semi-stochastic generalization of the Luria-Delbrück model, we provide a formal
definition of the time to cancer relapse. Applying the results previously described
for branching birth-death processes, we then derive the probability distribution
of such a time. We discuss many qualitative features of our model, especially in
the case where the primary tumor is resected at a given time. Then, we compare
our theoretical results with clinical data for five different cancer types.
In Chapter 4 we present our model of biomarker shedding. Here, the evo-
lution of a primary tumor releasing a specific biomarker in the bloodstream is
described as a two-type branching process. Our derivations, that are based on
the computation of probability generating functions for these two processes, are
then applied to the study of circulating tumor DNA and its use in liquid biopsies
for the early detection of cancer.
In Chapter 5 we then summarize our results and discuss some open questions.
4
1.2 Mathematical preliminaries
This section provides a brief and informal introduction to mathematical concepts
that are extensively used throughout this thesis. For each of these topics we then
point out more detailed and exhaustive references. Additionally, this introduction
is based on classical tools in probability theory and stochastic analysis, including
generating functions, Markov chains and Kolmogorov equations. These areas are
not covered here and are extensively discussed in many books such as [166, 103].
1.2.1 Branching birth-death processes
A birth-death process (Zt)t≥0 ([8]) is defined as a continuous time Markov chain
on the non-negative integers, whose transition probabilities satisfy, as ∆t→ 0,
P(Zt+∆t = j | Zt = i) =

αi∆t+ o(∆t) j = i+ 1 ,
βi∆t+ o(∆t) j = i− 1 ,
1− (αi + βi)∆t+ o(∆t) j = i ,
o(∆t) otherwise .
(1.1)
Birth-death processes have been extensively used in the last decades to describe
biological and physical phenomena ([44, 144, 160]). In the former context, Zt often
represents the number of individuals in a population alive at time t. When Zt is
made of i individuals, αi and βi denote the rates at which births and deaths occur,
respectively. The evolution of biological populations is frequently modelled under
the additional assumption that individuals reproduce and die independently of
each other with the same birth and death rates. In this case, the transition
rates in equation (1.1) depend linearly on the population size, i.e. αi = iα and
βi = iβ. Under the same hypotheses, we also notice that the progenies generated
by each individual evolve as independent and identically distributed processes.








s denotes the size of the i-th progeny after time s. The property above
characterizes a broad family of stochastic processes known as branching processes
[20]. As we just showed this family includes birth-death Markov chains with rates
proportional to the population size, which are therefore denominated branching
birth-death processes.
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For the branching birth-death process Zt defined before, α and β are called
birth and death rate, respectively. Denote λ = α − β the net growth rate of the
process. When λ > 0, λ = 0 or λ < 0 the process is called supercritical, critical or
subcritical, respectively. For any given initial condition Z0 = n0, we also denote
Z(n0)(x, t) =
∑∞
k=0 P(Zt = k | Z0 = n0)xk the probability generating function of
Zt. Thanks to the independence of progenies in branching processes, for every






An explicit expression ofZ(1)(x, t) can be derived from the backward Kolmogorov




(αx−β)e−λt−α(x−1) if α 6= β ,
1−(αt−1)(x−1)
1−αt(x−1) if α = β .
(1.4)
By combining equations (1.3) and (1.4) we immediately find an expression also
for Z(n0)(x, t). From here, we compute the first moments of Zt which yield
E[Zt | Z0 = n0] =
n0eλt if α 6= β ,n0 if α = β (1.5)
and








if α 6= β ,
2n0αt if α = β .
(1.6)
One of the fundamental questions related to a branching or a birth-death process
is if and when the process will go extinct. For a branching birth-death process
Zt, let us denote Ωt = {Zt > 0} and Ω∞ = {Zt > 0 for all t} the events of Zt
survival up to time t and eventual survival (or non-extinction), respectively. The
probability of the former event is equal to











)n0 if α = β . (1.7)
As t goes to infinity, we then find






if α > β ,
0 if α ≤ β .
(1.8)
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Let us now focus on a branching birth-death process starting with one individual,
and denote q = β/α. The generating function Z(1)(x, t) can be analytically
inverted (see later paragraph) to find the probability mass function of Zt. For
α 6= β we find















By taking the limit as λ → 0 we find instead the probability mass function for
the critical case
P(Zt = k | Z0 = 1) =






if k ≥ 1 .
(1.10)
When branching birth-death processes are employed to model the development
of biological populations, it is often important to study the size of these popu-
lations at relatively large times. To investigate this problem we will exploit a
classical property of branching processes [20]. Notice that the branching-birth-
death process Zt divided by its expected value,
Zt
E[Zt] = Zte
−λt, is a non-negative
martingale. Hence, by virtue of the martingale convergence theorem [61] there




−λt = W . (1.11)
The distribution of W can be derived from the probability generating function of
Zt, and it is explicitly given by (see again [20])




, x ≥ 0 . (1.12)
From this expression we see that W = 0 if and only if Zt goes extinct at some
time t, which happens with probability q. Hence, we find that
P(W ≤ x | Ω∞) = P(W ≤ x | W > 0) = 1− e−(1−q)x . (1.13)
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Branching birth-death processes with immigration
The evolution of biological populations can be greatly influenced by factors other
than the births and deaths of their individuals, and in particular by dynamics
of migration to and immigration from surrounding environments. To deal with
similar situations, here we introduce branching birth-death processes with im-
migration [8]. These are defined as continuous time Markov chains Zt on the
non-negative integers whose transition probabilities satisfy, as ∆t→ 0,
P(Zt+∆t = j | Zt = i) =

(ν + iα)∆t+ o(∆t) j = i+ 1 ,
iβ∆t+ o(∆t) j = i− 1 ,
1− i(α + β)∆t+ o(∆t) j = i ,
o(∆t) otherwise .
(1.14)
Let Z(n0)(x, t) denote the probability generating function for such a process, con-
ditioned on n0 ≥ 1 initial individuals. Following steps similar to those described
in the previous section, an explicit expression for Z(n0)(x, t) can be derived also





β(eλt − 1)− (βeλt − α)x
]n0
[αeλt − β − α(eλt − 1)x]n0+ν/α
if α 6= β ,
[x+ αt(1− x)]n0
[1 + αt(1− x)]n0−ν/α
if α = β .
(1.15)
In turn, from these expressions we can again derive the probability mass function
of Zt and its first moments. In particular, we find




if α 6= β ,
n0 + νt if α = β .
Probability mass functions and first moments from generating functions
In the previous paragraphs we have derived the probability mass function for the
process Zt by inverting its generating function. As similar inversion techniques
will frequently recur in the next chapters, we briefly discuss them here. Let (χt)t≥0
be a stochastic process and denote G(x, t) =
∑∞
k=0 P(χt = k)xk its probability
generating function. The mass function of χt follows by expanding G(x, t) around
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zero and is formally given by [61]








The expected value and variance of χt are instead equal to
E[χt] = ∂x G(x, t)|x=1, Var(χt) = ∂2x G(x, t)|x=1 + E[χt]− E[χt]2 .
In a few cases, the k-th derivative of the generating function is explicitly com-
putable, thus allowing to find an analytic formula for the probability mass func-
tion of χt. The expression for Z
(1)(x, t) given by equation (1.4) is an example
of such generating functions and from it we directly derived the probabilities
P(Zt = k | Z0 = 1) - see equations (1.9) and (1.10). For most generating func-
tions, however, this analytical inversion is not feasible and we have to compute the
probability mass function numerically. Algorithms for this numerical procedure
are based on techniques for series expansions of analytical functions, which are
implemented as Series in both Mathematica (here see also NSeries) and Maple.
For more details on the numerical inversion of probability generating functions
we refer to [1, 41].
Stochastic simulations
To obtain the stochastic simulations of branching birth-death processes shown
in this thesis we employed the Gillespie algorithm [74], which can be used to
simulate more general Markov processes as well. In short, this algorithm relies
on the property that for a Markov chain in a given state j, the time to the
next jump is exponentially distributed and the mean of this distribution is the
reciprocal of the total rate γj at which the process leaves state j. To build a
realization of the process it is thus sufficient to iteratively update the total rate
γj, compute the next interevent time by sampling from an Exp(1/γj) distribution
and then determine the chain transition from the jump probabilities.
1.2.2 The extreme value theory
Many results presented in this thesis rely on the probability distribution of first
passage times to a given size in branching birth-death processes, and in particu-
lar on their asymptotic form for large sizes. As we will discuss in detail in next
chapter, these passage times are closely related to probability distributions aris-
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ing in order statistics and extreme value theory. Hence, we now recall some basic
notions in these fields. Classical references for these topics are [47, 6, 162].
Let X1, X2, . . . , Xn be a family of continuous and real-valued random variables
defined on a common probability space. For every event ω in this space we can
then arrange the values X1(ω), X2(ω), . . . , Xn(ω) in nondecreasing order. This
allows us to introduce new random variables Xi,n, defined by the condition
X1,n(ω) < X2,n(ω) < · · · < Xn,n(ω) for every ω .
The random variable Xk,n is called the k-th order statistic of the original sample.
Suppose now that Xi are i.i.d. with common cumulative distribution and density
functions F and f , respectively. Then, the density function of the k-th order
statistic Xk,n, denoted by fk,n, is given by
fk,n(x) =
n!
(k − 1)!(n− k)!
(F (x))k−1 (1− F (x))n−k f(x) .
Let us here mention a special property of the order statistics of exponential dis-
tributions. If the random variables Xi are i.i.d. Exp(α), we can use the previous











where Ei denote i.i.d. standard exponential random variables. Such a distribu-
tional identity is known as the Renyi representation for the order statistics of
exponential random variables [161].
Extreme value theory is concerned with the asymptotic behaviour of order
statistics when the sample size gets large. More precisely, consider again a family
of i.i.d. random variables X1, X2, . . . , Xn with common distribution function F
and denote the upper end point of F as ω(F ) = sup{x : F (x) < 1}. Then, we
have
P(Xn,n ≤ x) = P(X1 ≤ x, . . . , Xn ≤ x) = F n(x)
and so Xn,n converges almost surely to ω(F ). The aim of extreme value the-
ory is then to find normalizing constants an, bn and non-degenerate distribution
10







−→ G(x) as n→∞ . (1.16)
If such an, bn and G(x) exist, then the distribution function F is said to belong to
the domain of attraction of G. Furthermore, two limit functions G and G′ are said
to be of the same type if there exist constants a and b such that G′(x) = G(ax+b)
for all x. The Fisher-Tippett-Gnedenko theorem states that there exist only three
types of limit probability distributions for the maxima of i.i.d. random variables.









if x < 0
0 if x ≥ 0
for some γ > 0
and are equivalently referred to as type I, II and III or as Gumbel, Fréchet and
Weibull types, respectively. Many tests have been developed to assess whether
a given distribution function belongs to the domain of attraction of one of these
three types. For references on these methods see [121, 48].
To conclude this section, we provide a few more details about the Gumbel
distribution. First, note that the exponential distribution belongs to its domain
of attraction. To see this, it is sufficient to check that equation (1.16) is satisfied
by F (x) = 1−e−αx, G(x) = e−ex , an = 1α and bn = −
log(n)
α
. A direct generalization
of the Fisher-Tippett-Gnedenko theorem (see [47]) shows that there exist three
types of possible nondegenerate distributions also for the limit of the k-th largest
of i.i.d. random variables. Using the definitions in [5, 154], we characterize one of
these types by saying that a continuous random variableX with support (−∞,∞)
follows the k-th generalized Gumbel distribution with parameters a ∈ R and
b > 0, X ∼ Gumbk(a, b), if and only if its cumulative distribution function is of
the form











If X ∼ Gumbk(a, b), then we have
E[X] = a− b ψ0(k) , Var(X) = b2 ψ1(k) , (1.18)
where ψ0 and ψ1 denote the digamma and trigamma functions, respectively [95].
Let us here provide distinct notations for the Gumbel limit of the largest and
smallest extremes of a sample. The former coincides with the previous general
case when k = 1, while the latter follows by a small adaptation. We say that a
continuous random variable X with support (−∞,∞) follows a Gumbel distri-
bution for the maximum with parameters a ∈ R and b > 0, X ∼ Gumbmax(a, b),
if and only if its cumulative distribution function is of the form [95]







This distribution generally characterizes the maximum of independent random
variables with exponential tail, and so it is a right skewed distribution. Similarly,
we say that a continuous random variable X with support (−∞,∞) follows a
Gumbel distribution for the minimum with parameters a ∈ R and b < 0, and we
denote it X ∼ Gumbmin(a, b), if and only if its cumulative distribution function
is of the form







This distribution describes the minimum of independent random variables with
an exponential “nose”, and its density is left skewed.
Here, let us anticipate that in the rest of this thesis, with a little abuse of
notation, we will use the same symbol ∼ to denote the asymptotic behaviour
of a function and the distribution of a random variable. For example, we will
encounter both expressions like P(X ≤ t) ∼ G(a, b; t) and X ∼ Gumbmin(a, b),
whose respective meanings will be unambiguously specified by the context.
To conclude this section let us note that, as ψ0(1) = γE and ψ1(1) = π
2/6, if
X1 ∼ Gumbmax(a1, b1) and X2 ∼ Gumbmin(a2, b2), for i = 1, 2 we have





where γE ≈ 0.5772 denotes the Euler-Mascheroni constant.
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1.2.3 Two-type processes and stochastic seeding
The models presented in this thesis are based on the assumption that cells from
the primary tumor stochastically seed a second population. Intuitively, if the
number of the cancerous cells alive at time t is At and the seeding rate per cell
is ν, then at time t individuals of the second population are generated at rate
νAt. The form of this rate therefore depends on how we model the size At of the
primary tumor. In particular, when At is described by a deterministic function
or by a stochastic process, the second population is seeded as a non-homogeneous
Poisson process or as a Cox process, respectively. Here we briefly review some
of the main properties of these processes. More details can be found in classical
references such as [165, 176, 45].
Non-homogeneous Poisson processes
A stochastic process (Kt)t≥0 taking values on the non-negative integers, such that
K0 = 0 and Kt ≥ Ks almost surely for every s ≤ t, is called a counting process.
Let ν(t) : [0,∞)→ [0,∞) be an integrable function. If a counting process (Kt)t≥0
is such that Kt1 − Ks1 and Kt2 − Ks2 are independent for any pair of disjoint
intervals [s1, t1] and [s2, t2], and additionally satisfies
P(Kt+∆t −Kt = n) =

1− ν(t)∆t+ o(∆t) if n = 0 ,
ν(t)∆t+ o(∆t) if n = 1 ,
o(∆t) if n ≥ 2
for every t, then it is called a non-homogeneous Poisson process with rate (or
intensity) ν(t). This process gets its name from the fundamental property that









Clearly, when the rate function ν(t) is constant, Kt is a standard time homoge-
neous Poisson process.
Now, suppose that pi(t) : R → [0, 1], for i = 1, . . . , n, are n continuous
functions such that
∑n
i=1 pi(t) = 1 for every t. Then, we can split the non-
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t denotes a non-homogeneous Poisson process with intensity ν(t)pi(t).
This property is called the splitting or thinning property of Poisson processes.
To conclude this section, let us mention that the stochastic simulations of
non-homogeneous Poisson processes presented in this thesis are obtained through
the Çinlar algorithm. Briefly, such algorithm is based on the result that a set of
random variables {σi}i∈N corresponds to the arrival times in a non-homogeneous
Poisson process Kt with expectation function Λ(t) :=
∫ t
0
ν(u)du if and only if
the random variables {Λ(σi)}i∈N correspond to the arrival times of a homogenous
Poisson process with rate one. This result was first proved in [35], and allows to
simulate Kt by iteratively sampling from a standard exponential distribution and
then inverting the expectation function Λ(t).
Cox processes
Cox processes generalize non-homogeneous Poisson processes by letting the in-
tensity function to be stochastic. More precisely, let (νt)t≥0 be a random function
taking values on the non-negative real line. Suppose that (νt)t≥0 is almost surely
locally integrable, i.e. such that
∫ b
a
νtdt < ∞ with probability 1 for every closed
and bounded real interval [a, b]. A stochastic process (Kt)t≥0 is then called a Cox
process if conditional on (νt)t≥0 it is a non-homogenous Poisson process with rate
(νt)t≥0. In particular, we have that for any interval [s, t] such Kt satisfies











Hitting times for branching
birth-death processes
2.1 Introduction
The time taken by a stochastic process to reach a specified state (or set of states)
for the first time is usually referred to as first passage (or hitting) time to such
state. First passage times have been extensively studied since the beginning of
the 20th century and, partly due to the generality of their definition, found ap-
plications in a great number of diverse fields. For example, they can be used
to plan the execution of a financial operation when a stock price reaches a cer-
tain threshold, or to model the triggering of chemical reactions when a molecular
system assumes specific configurations. For the main properties of first passage
times and a survey on some of their applications (e.g. to electrostatics, reaction
phenomena and finance) we refer to [134, 157].
Around the same years, stochastic processes started to be widely employed
in biology. In this context, first passage times have allowed us to study fea-
tures of molecular transcription and translation, cellular mutation and disease,
organismic evolution and many other processes [40]. In particular, in the field of
population dynamics hitting times are often used to describe the time taken by
a population to get extinct, or to grow to a certain size. Such a mathematical
description applies to different kinds of biological species whose evolutionary dy-
namics - depending on the species characteristics and on modelling assumptions
- are well represented by specific stochastic processes. For example, branching
birth-death processes as those introduced in Section 1.2.1 are often employed for
the modelling of cellular populations. An accessible review of this and other bi-
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ological applications of birth-death processes is provided in [144].
For this type of processes, the main results concerning first passage times
were first obtained by Samuel Karlin and James McGregor in the late 1950s
[98, 99, 102]. In particular, by exploiting the family of orthogonal polynomials
associated with a birth-death Markov chain, they proved that the probability
distribution of hitting times is completely determined by the eigenvalues of the
infinitesimal generator matrix underlying the process. While this property rep-
resents a powerful tool to study a broad range of birth-death chains, tractable
expressions for the required eigenvalues are often impossible to obtain, and so
simpler quantities like the expectation of hitting times [155] or asymptotic forms
of their distribution are investigated.
In this thesis, we model the evolution of populations of cancerous cells as
branching birth-death processes. For our applications we are especially inter-
ested in the first time that such populations take to reach a large detectable size
M . Furthermore, as the modelled population might not grow to size M before
getting extinct, we aim to obtain the probability distribution of that time con-
ditioned on absorption in M . With this motivation in mind, in this chapter we
review classical results for first passage times in a branching birth-death process,
conditioned on its survival until reaching a certain size. While the majority of
these results are known, they have often been derived independently of each other
and using different mathematical approaches. We thus aim to discuss the proba-
bility distributions of hitting times in a coherent and accessible fashion, allowing
to gain insight into the fundamental properties of these random variables. In this
vein, our main contribution constists in providing a mathematical intuition for
the asymptotic behaviour of first passage times to a large size.
The rest of this chapter is organized as follows. In Section 2.2 we first define
hitting times for birth-death processes. We then discuss some simple properties
of branching pure birth processes, that can be used as a reference example for the
subsequent derivations. In Section 2.3 we state the Karlin-McGregor theorem,
and we exploit it to derive the exact probability distribution of the hitting time to
a given size M . In order to do so, we consider separately noncritical and critical
processes. Then, in Section 2.4 we present the asymptotic distribution of hitting
times to a large size, distinguishing again between noncritical and critical cases.
It is well known that for noncritical processes these asymptotic results are closely
related to extreme value distributions. At the end of this section we thus provide
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a mathematical explanation for such a connection, and discuss the validity of
this argument for the critical case. Finally, Section 2.5 summarizes the material
presented.
The derivations of the simpler mathematical results discussed in this chapter
are presented below their statement. More involved proofs are instead shown in
Appendix A, while for some classical ones we will refer to the relevant literature.
2.2 Preliminaries
In this section we provide the main definitions and notation that will be used
throughout the chapter. Then, we introduce some of the mathematical tools
necessary to study hitting times distributions by briefly discussing the special
case of a branching pure birth process.
2.2.1 Definitions and notation
Let Zt be a branching birth-death processes on the non-negative integers, as
defined in Section 1.2.1. By definition these processes are skip-free, i.e. they do
not allow for one-step transitions from a state to a non-neighbouring one. As a
consequence, the first passage time of Zt to a size M is formally defined as
TM = inf{t > 0 : Zt = M} . (2.1)
Depending on the realization of the process, this time can be finite or infinite. In
particular, if Zt gets extinct before it reaches size M we set TM = ∞. For our
applications we will often be interested in studying the probability distribution
of TM conditional on Zt reaching size M in a finite time. For this reason, on top
of the survival events Ωt and Ω∞ introduced in Section 1.2.1, we define
Ωj = {Zt = j for some t ≥ 0}
as the event of Zt survival up to size j, for every j ≥ 1.
The probability distribution of the hitting time TM also depends on the initial
size of the process Zt. In the following, we will thus express the conditioning on
a given initial state (or population size) through the notation
Pi( · ) = P( · | Z0 = i) .
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Moreover, our analysis of hitting times will occasionally require us to consider
their distributions additionally conditioned on Zt always staying above or below
its initial size. To this purpose, we introduce the following notations
Pi(·) = P(· | Z0 = i, Zs ≥ i for all s) ,
Pī(·) = P(· | Z0 = i, Zs ≤ i for all s) .
By recalling the definition of Zt eventual survival we see in particular that
P1(Tj ≤ t) = P(Tj ≤ t | Z0 = 1,Ω∞) .
2.2.2 A reference example: branching pure-birth processes
Let Zt be a branching pure birth process, i.e. a branching birth-death process
with death rate β = 0. By definition, Zt is a Markov chain representing the
size of a population where each individual splits independently at rate α and
cannot die. Hence, the lifetime of each individual in such a population is expo-
nentially distributed with rate α. We define the inter-event times for Zt as the
random variables Yi := Ti+1−Ti, where Ti denotes the first passage time to i (see





Now, suppose that Z0 = 1 and for every individual let us label its two children
as 0 and 1, respectively. Then, every individual alive at a given time is uniquely
associated to a binary sequence starting with a zero, which labels the first ances-
tor. Denote la the lifespan of the individual labelled by the binary sequence a.
Because of the previous observations, we have that la ∼ Exp(α) for every label
a. Moreover, since we are assuming that Z0 = 1, we have T1 = 0 and hence
Y1 = T2 = l{0} ∼ Exp(α) .
The second inter-event time is then determined by the minimum of the lifespans
l{0,0} and l{0,1}, which are again independent Exp(α) random variables. Therefore
we have
Y2 ∼ Exp(2α) .
Now, let us loosely refer to the length of a binary sequence a as the generation of
the individual labelled by a. Without loss of generality, suppose that among the
18
two individuals in the second generation the one labelled by {0, 1} was the first one
to divide, determining the time Y2. Then, the lifetime left for the other individual
in the second generation, l{0,0}−Y2, is still an Exp(α) random variable thanks to
the memoryless property of exponential distributions. As a consequence, we find
Y3 = min
(
l{0,1,0}, l{0,1,1}, l{0,0} − Y2
)
∼ Exp(3α) .
This argument is visualized in Figure 2.1, and can be extended to prove (e.g. by
induction) that
Yi ∼ Exp(iα) for every i ≥ 1 . (2.3)
By joining equations (2.2) and (2.3) we thus see that for a branching pure birth
process starting with n0 ≥ 1 individuals







On the other hand, the parameters of the exponential random variables in equa-













where Ei are i.i.d. standard exponentials (i.e. Exp(1)). The right hand side of the
last equation is then recognized as the Rényi representation for the (M −n0 + 1)-
th order statistic from M − 1 exponential random variables with parameter α
(see Section 1.2.2). In other words, we have that for a branching pure birth
process with birth rate α and n0 initial individuals the first passage time TM is
distributed like the n0-th largest out of M−1 Exp(α) random variables. Here, let
us recall that the order statistics coming from exponentially distributed samples
belong to the (generalized) Gumbel domain of attraction (see again Section 1.2.2).
But what is the intuition behind TM behaving like an order statistic in the first
place? To answer this question, let us consider a branching pure death process Z∗t
with death rate α and such that Z∗0 = M − 1. We denote T ∗i and Y ∗i the hitting
time to size i and the i-th inter-event time for Z∗t , respectively. A reasoning




Y ∗i ∼ Exp(iα) .
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Figure 2.1: Inter-event times distributions in a pure birth process.
Therefore, by applying without ambiguity the same notations introduced in Sec-
tion 2.2.1 to Z∗t , we find P1(TM ≤ t) = PM−1(T ∗0 ≤ t). But since T ∗0 is the time
to extinction of a pure death process, it coincides with the maximum lifespan of
its initial individuals. Similarly T ∗1 , that has the same distribution of the hitting
time TM conditional on Z0 = 2, is equal to the second longest lifespan of Z
∗
t
initial individuals, and so on.
In the rest of this chapter we will exploit and generalize some of the argu-
ments presented here to study the distribution of TM for branching birth-death
processes. To conclude this section let us mention that in the branching pure
birth case, the asymptotic Gumbel limit of hitting times distributions was first
noticed by Blackwell and Kendall [26] and then studied in great details by Waugh
in a series of papers (see [201, 202, 204]). All these authors derived such a result
by expressing TM in terms of the so-called stochastic lag S = − log(W )α , where W
is the classic martingale limit for branching processes (see equation (1.11)).
2.3 Exact hitting times distributions
In this section we derive the exact probability distribution of the hitting time to
size M for a branching birth-death process, conditioned on the process survival
up to M . Such a distribution follows from a classical theorem that applies to a
broader family of birth-death processes and that was originally shown by Samuel
Karlin and James McGregor.
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2.3.1 Karlin-McGregor theorem
Consider a birth-death process Zt defined on the non-negative integers and with
reflecting boundary at 0, i.e. such that
P(Ẑ1 = 1 | Ẑ0 = 0) = 1,
where Ẑn denotes the jump process associated to Zt. The following theorem
characterizes the probability distribution of the first passage time to M for such
a process.
Theorem 2.3.1. Let Zt be a birth-death process on {0, . . . ,M} such that Z0 = 0.
If 0 is a reflecting boundary for the process and M is treated as an absorbing
state, then the first passage time TM is distributed as the sum of M exponential
random variables whose parameters are the negatives of the non-zero eigenvalues
of the underlying infinitesimal generator.
Notice that to construct the infinitesimal generator the theorem refers to it
is sufficient to truncate the generator of the birth-death chain Zt between 0 and
M and additionally set P(Ẑ1 = M | Ẑ0 = M) = 1. The result above has been
derived in different ways. As we mentioned before the first authors to state it
and prove it were Karlin and McGregor [102]. Their proof relies on the theory
of orthogonal polynomials associated to a birth-death process, developed by the
same authors, that we will briefly introduce in the next paragraph. The first
probabilistic proof of Theorem 2.3.1 was presented instead by Persi Diaconis and
Laurent Miclo [51]. All these demonstrations are quite involved and we thus do
not report them here. For more details we refer to the two papers cited above
and in particular to the historical notes discussed in [51], that remark additional
contributions. Notice, however, that from a modelling standpoint no clear inter-
pretation of the exponential random variables in the theorem statement has been
provided yet.
Before we discuss the application of Theorem 2.3.1 to branching birth-death
processes, let us show how we can exploit it to compute explicitly the probability
density function of TM when the birth-death process Zt starts with a given number
n0 ≥ 1 of individuals.
Proposition 2.3.2. Let Zt be a birth-death process on {0, 1, 2, . . . } such that 0 is
a reflecting state. For every k, let Qk be the infinitesimal generator of the process
Zt restricted between 0 and k, when Z0 = 0 and k is treated as an absorbing
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state. Moreover, suppose that 0 < n0 < M and define λi, i = 1, . . . ,M and
µj, j = 1, . . . , n0 as the negatives of the non-zero eigenvalues of QM and Qn0,
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The proof of this proposition is presented in Appendix A.1. We now provide
a short introduction to the theory of orthogonal polynomials associated with a
birth-death process.
Associated orthogonal polynomials
The relationship between birth-death processes and orthogonal polynomials was
first highlighted in a series of seminal papers from Karlin and McGregor [98, 99,
100, 101, 102]. Their work proved that the transition probabilities of any given
birth-death process can be expressed in terms of a family of polynomials and a
Borel measure associated to the process. Since then, many other properties of a
birth-death process have been described in terms of these polynomials, including
the probability distributions of hitting times. In this paragraph we briefly review
some of these topics, while for more details and some of the classical literature
on the subject we refer to [104, 181, 132, 91, 194].
Let Zt be a birth-death process on the non-negative integers as defined by
equation (1.1). Its transition probabilities admit the following representation





where the coefficients πj are given by
π0 = 0, πn =
α0α1 · · ·αn−1
β1β2 · · · βn
,
ψ is a Borel measure on [0,∞) of total mass 1 and {Qn} is a family of polynomials
satisfying the recurrence relation
αnQn+1(x) = (αn + βn − x)Qn(x)− βnQn−1(x), n > 1 ,
α0Q1(x) = α0 + β0 − x, Q0(x) = 1
(2.6)
and orthogonal with respect to ψ, i.e. such that∫ ∞
0
Qi(x)Qj(x)ψ(dx) > 0 if and only if i 6= j .
The measure ψ and the sequence {Qn} are called the spectral measure and the
orthogonal polynomials associated with Zt, respectively. Under additional as-
sumptions it is possible to prove that the measure ψ is uniquely determined
by the transition rates of the birth-death process. Several recurrence relations
similar to that in equation (2.6) can be derived by applying simple algebraic
transformations. As an example, consider the family of polynomials defined by
Rn(x) = (−1)nα0 · · ·αn−1Qn(−x) (2.7)
for every n ≥ 0. These polynomials satisfy (see e.g. [193])
Rn+1(x) = (−x− αn − βn)Rn(x)− αn−1βnRn−1(x), n ≥ 1 ,
R1(x) = −x− α0 − β0, R0(x) = 1 .
(2.8)
Now, let us denote Qn the infinitesimal generator of a birth-death process Zt
stopped at n. It is then easy to check that the recurrence relation (2.8) defines
precisely the family of characteristic polynomials Rn(x) = det(Qn − xIn), where
In denotes the n×n identity matrix. The zeros of these polynomials thus coincide
with the eigenvalues of Qn, which in turn provides the link between Theorem 2.3.1
and the family {Qn}. Unfortunately, this family reduces to a known class of
polynomials only in few cases. As we will see in the next section, one of these
special cases is represented by critical branching birth-death processes and hence
some of its properties will directly follow by the form of the associated orthogonal
polynomials. The same properties for noncritical processes will instead require
alternative derivations.
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Conditional branching birth-death processes
Now, suppose that Zt is a branching birth-death process and let us denote Ẑt its
embedded Markov chain (or associated jump process). Theorem 2.3.1 does not
apply directly to this case, since 0 is an absorbing state. However, consider Zt
conditioned on survival up to size M , and denote p̃i,j the corresponding condi-
tional one-step transition probabilities. In particular, we have
p̃1,0 = P(Ẑ1 = 0 | Ẑ0 = 1,ΩM) = 0 .
The conditional process thus reduces to a Markov chain defined on {1, . . . ,M}
such that the lower end of its state space, i.e. 1, is a reflecting boundary. Theo-
rem 2.3.1 can now be applied to such a process by simply relabelling the states
through the map i 7→ i− 1. The first passage time to M is therefore distributed
as the sum of M − 1 exponential random variables, whose parameters depend on
the conditional transition probabilities p̃i,j. In the following sections we derive
explicit expressions for these probabilities and discuss consequent properties of
hitting times distributions.
2.3.2 Noncritical case
Let Zt be a supercritical branching birth-death process with birth rate α and
death rate β. If Z0 = 1, its extinction probability is equal to q = β/α < 1 (see
equation (1.8)). Consider such a process restricted to {0, . . . ,M}, for a fixed





(1 + q)(1− qi)
if j = i+ 1 ,
q(1− qi−1)
(1 + q)(1− qi)
if j = i− 1 ,
0 otherwise ,
(2.9)
where 0 ≤ i, j ≤ M . A full derivation of these expressions can be found for
example in [203]. Notice that by conditioning on ΩM we leave unchanged the rate
of inter-event times, which for every individual of Zt is equal to α+β = α(1 + q).
Hence, if Q̃M denotes the infinitesimal generator matrix of Zt conditioned on Ω
M
and q̃i,j its entries, the previous observation implies that q̃i,i = −iα(1 + q) for
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if j = i+ 1 ,




if j = i− 1 ,
0 otherwise ,
(2.10)
for 0 ≤ i, j ≤ M . Furthermore, we observe that the expressions for q̃i,j and p̃i,j
only depend on the states i and j and not on the final size M . Intuitively, this
is due to the fact that each of these rates and probabilities govern the process
simply conditional on reaching state max{i, j} before getting extinct. Hence, we
have
P(Ẑ1 = j | Ẑ0 = i,ΩM) = P(Ẑ1 = j | Ẑ0 = i,Ωmax{i,j}) = p̃i,j ,
which also explains why we do not include M in their notation. As a consequence,
we have that for every n > 1 the infinitesimal generator Q̃n can be constructed
from Q̃n−1 by simply adding to it the (n+ 1)-th row and column.
Now let us denote Rn(x) = det(Q̃n−xIn+1), where In represents the n×n iden-
tity matrix. The previous observation allows us to apply to these characteristic
polynomials the same argument described in the previous section. Specifically, by
expanding Rn(x) over the two non-zero elements of the (n+1)-th row, q̃n−1,n and
q̃n,n, we can express it in terms of Rn−1(x) and Rn−2(x). The sequence {Rn(x)}n
is then uniquely identified by the following recursive relation
R0(x) = 1 , R1(x) = −α(1 + q)− x ,
Rn(x) = [−nα(1 + q)− x]Rn−1(x)− n(n− 1)α2q Rn−2(x)
(2.11)
for all n ≥ 2. Referring now to the discussion presented at the end of Section 2.3.1,
we recall that the distribution of the hitting time TM conditioned on Ω
M is
determined - as a result of Theorem 2.3.1 - by the eigenvalues of the infinitesimal













where rM−1,i denote the M −1 zeros of the polynomial RM−1(x). These distribu-
tions, for different values of the rates α and β, are plotted in Figure 2.2. As an
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example, we notice that when Z0 = 1, the first passage time to 2 conditional on
Ω2 is distributed like the first inter-event time, as the process cannot transition
to 0. Such a time is exponentially distributed with parameter α(1 + q), which is
equal to −r1,1 (see equation (2.11)).
In general, however, many properties of the zeros rM,i are not known since the
polynomials Rn(x) identified by the recurrence relation (2.11) - or equivalently
the associated orthogonal polynomials Qn(x) obtained by inverting equation (2.7)
- do not correspond to classical families. Hence, while the discussion above yields
the exact distribution of TM , it is hard to derive its asymptotic limit for large M
or other properties of the process Zt from similar arguments.
Figure 2.2: Conditional first passage time densities in a supercritical
branching birth-death process. The histograms represent the distribution of the
hitting time to M = 100 obtained from 105 simulations of a supercritical branching
birth-death process with the birth and death rates indicated in the legend and conditioned
on reaching M . The solid lines show instead the corresponding conditional theoretical
densities computed from Theorem 2.3.1. Already for M = 100 and different values of
the birth and death rates, these densities perfectly match the simulated data.
A different scenario occurs when studying critical branching birth-death pro-
cesses. Before we address this latter case, let us conclude this section by mention-
ing a formula for the expected value of the hitting time TM and how the previous
results apply to subcritical branching birth-death processes.
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Proposition 2.3.3. Let Zt be a supercritical branching birth-death process with
birth rate α, death rate β and such that Z0 = n0 ≥ 1. Then
E
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The proof of this result as well as a formula for the variance is provided in
Appendix A.2.1.
Subcritical case
Let Zt be a subcritical branching birth-death process with birth rate β and death
rate α, where α > β. Then, its transition probabilities conditional on survival
up to M have the same form as in equation (2.9) (see e.g. [203]). The previous
reasoning can thus be repeated and applied also to this case. In particular we find
that, by conditioning on survival up to M , the hitting times TM in two noncritical
branching birth-death processes with birth and death rates swapped have the
same probability distribution. A similar “reversal” argument will be explored
more in depth in Section 2.4 to gain insight into the asymptotic behaviour for
large sizes of these distributions.
2.3.3 Critical case
By adapting the argument employed in the noncritical case, we can derive the
distribution of hitting times for critical branching birth-death processes as well. In
this case, the family of orthogonal polynomials associated with these processes are
well known and so the distribution provided by Theorem 2.3.1 is more tractable.
In particular, we find the following
Proposition 2.3.4. Let Zt be a critical branching birth-death process with the
same birth and death rates α and such that Z0 = 1. Then, for every M > 1,
the first passage time to M conditioned on survival up to M is distributed like a
sum of independent exponential random variables with parameters αλM−1,i, where
λM−1,i are the M − 1 zeros of the associated Laguerre polynomial L(1)M−1(λ).
Sketch of the proof. Let us employ the same notations used in the previous sec-
tion. We consider the critical branching birth-death process Zt defined in the
statement and restricted to {0, . . . ,M}. The one-step transition probabilities
and the transition rates for such a process follow by taking the limit as q → 1 in
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if j = i+ 1 ,
i− 1
2i




α(i+ 1) if j = i+ 1 ,
−2αi if j = i ,
α(i− 1) if j = i− 1 ,
0 otherwise ,
where 0 ≤ i, j ≤ M . The recurrence relation for the characteristic polynomials
Rn(x) = det(Q̃n−xIn+1) is obtained by plugging the rates above in equation (2.8),
or by taking again the limit as q → 1 in equation (2.11), and is given by
Rn(x) = (−2αn− x)Rn−1(x)− α2n(n− 1)Rn−2(x), n ≥ 2 ,
R1(x) = −x− 2α, R0(x) = 1 .
Let us now set α = 1. From equation (2.7), we see that in this case the orthogonal
polynomials associated to Zt are equal to Qn(x) =
(−1)n
n!
Rn(−x) , and thus satisfy
the recurrence relation
nQn(x) = (2n− x)Qn−1(x)− nQn−2(x), n ≥ 2 ,
Q1(x) = 2− x, Q0(x) = 1 .
This last relation determines the associated Laguerre polynomials of index ν = 1














By construction, the zeros of RM(x) coincide with those of L
(1)
M (x). Extending this
argument to the case α 6= 1, we find that RM(x) = (−1)MαMM !L(1)M (−x/α). In
particular, this means that if λM,i denotes the i-th zero of L
(1)
M (x), the eigenvalues
of Q̃M are equal to αλM,i. The rest of the proof then follows as in the noncritical
case.
The distribution of TM for M = 100 and different values of α is visualized in
Figure 2.3. As for the previous section, we conclude our analysis of the critical
case by providing expressions for the conditional expectation of TM .
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Figure 2.3: Conditional first passage time densities in a critical branching
birth-death process. The histograms show the distribution of the hitting time to
M = 100 obtained from 105 simulations of a critical branching birth-death process
with the birth rate indicated in the legend and conditional on absorption in M . The
solid lines plot instead the corresponding conditional theoretical densities computed from
Proposition 2.3.4. Already for M = 100 and different values of the birth rate, these
densities perfectly match the simulated data.
Proposition 2.3.5. Let Zt be a critical branching birth-death process with birth
and death rates α. Then
E
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The derivation of this expression, as well as one for the variance, is presented in
Appendix A.2.2. Such a proof follows the same argument used for the supercritical
case. However, since in this case the parameters λM,i are zeros of a known family
of polynomials, the same result can be computed by summing up the reciprocals
of αλM−1,i (and applying Proposition 2.3.2 if n0 > 1). The value of this sum is
then provided by Viete’s formulas (see [195]).
2.4 Asymptotic hitting times distributions
In this section we discuss the asymptotic behaviour of the hitting time distribu-




Theorem 2.4.1. Let Zt be a supercritical branching birth-death process with birth
rate α, death rate β and such that Z0 = 1. Then, as M gets large, the distribution
of the first passage time TM asymptotically converges to
P1(TM ≤ t) ∼ e−(1−q)Me
−λt
, (2.14)
where λ = α − β denotes the net growth rate of the process and q = β/α its
extinction probability.
Proof. When Z0 = 1, we know that the process Zt/e
λt converges almost surely
to a martingale limit (see equation (1.11)) as t → ∞. Since limM→∞ TM
a.s.
= ∞,






= W . (2.15)
The cumulative distribution of W is also known. In particular, we saw that for
Z0 = 1 and conditioned on Ω∞, the random variable W follows an exponential
distribution with parameter 1 − q (see equation (1.13)). Therefore, by joining
this result and equation (2.15) we find




∼ 1− P1(W ≤Me−λt) = e−(1−q)Me
−λt
.
Figure 2.4 shows a comparison between the exact and asymptotic distributions
of TM , which become undistinguishable already for relatively small values of M .
A similar approach to that used in the previous proof can also be employed to
derive the asymptotic distribution of TM conditional on n0 > 1 initial individuals.
Indeed, we find
Proposition 2.4.2. Let Zt be a supercritical branching birth-death process with
birth rate α and death rate β. Then, for M large, the distribution of TM condi-
tioned on non-extinction and n0 initial individuals asymptotically converges to




















, j = 0, . . . , n0 − 1 .
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This last proposition, whose detailed proof can be found in Appendix A.3.1,
explicitly shows that when n0 > 1 the conditional distribution of TM asymptot-
ically converges to a mixture of generalized Gumbel distributions with weights
cj. The cumulative distribution function of these distributions is given by equa-
tion (1.17).
Figure 2.4: Comparison between exact and asymptotic distributions of hit-
ting times in a supercritical branching birth-death process. The histograms
in the top panel show the distribution of the first passage time to M = 10, 50, 90, 130
obtained from 105 simulations of a supercritical branching birth-death process with birth
rate α = 0.3 and death rate β = 0.15 day−1. In the same panel, solid lines represent
the corresponding exact theoretical densities computed from Theorem 2.3.1, while the
dashed lines plot the asymptotic Gumbel densities derived from equation (2.14). The
exact and asymptotic distributions differ for M very small and become almost undis-
tinguishable around M = 100. This result is confirmed by the two bottom panels, which
compare the simulated expectation and variance of TM with their exact and asymptotic
expression (see equations (2.12) and (A.7), and Proposition 2.4.3 ,respectively).
An expression equivalent to equation (2.16) was first obtained in [208] through
a different mathematical derivation. As we pointed out at the end of Section 2.2.2,
Waugh did instead exploit a martingale argument and applied it to study branch-
ing pure birth processes, but he did not carry out an explicit computation of
P1(TM ≤ t) in the birth-death case. Finally, we notice that for n0 = 1, the proof
we have just showed has been recently employed in [53].
Following our presentation of the exact results for hitting times distributions
in noncritical branching birth-death processes, we now conclude this section by
providing the asymptotic mean and variance of these times for large sizes, and
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with a brief discussion of the subcritical case.
Proposition 2.4.3. Let Zt be a supercritical branching birth-death process with
birth rate α and death rate β. Then, asymptotically for M large, we have
E
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log(M) + C1 ,
Var
(
TM | Z0 = n0,ΩM
)
∼ C2 ,






















In these expressions, the coefficients cj are defined as in Proposition 2.4.2, while
ψ0 and ψ1 denote the digamma and trigamma functions, respectively.
The proof of this result is shown in Appendix A.2.1. Notice that since ψ0(1) = γE
and ψ1(1) = π
2/6, Proposition 2.4.3 implies in particular that
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where γE ≈ 0.5772 is the Euler-Mascheroni constant.
Subcritical case
Recalling the results presented at the end of Section 2.3.2, we know that the
distributions of hitting times for subcritical branching birth-death processes fol-
lows straightforwardly from the corresponding results for a supercritical process
with rates swapped. The same argument can be used to derive the asymptotic
behaviour of these distributions. In particular, we find that if Zt is a subcritical
branching birth-death process with birth rate β, death rate α and starting with
one individual, then asymptotically for M large




In a similar fashion we can then exploit the previous results to obtain the distri-
bution of TM conditioned on n0 > 1 initial individuals and its first moments.
2.4.2 Critical case
As shown by Proposition 2.3.4, the distribution of the first hitting time to M in a
critical branching birth-death process depends entirely on the zeros of L
(1)
M−1(λ).
As M gets large, these zero converge to those of a Bessel function. Hence, by
combining their asymptotic behaviour and Proposition 2.3.4 we find the following
Theorem 2.4.4. Let Zt be a critical branching birth-death process with birth and
death rates α and starting with one individual. Then, as M becomes large, the




X i, where X i are independent random variables such that





, i = 1, . . . ,M − 1 ,
and ji denotes the i-th positive zero of the Bessel function of the first kind J1(z).
The proof of Theorem 2.4.4 is presented in Appendix A.3.2. A comparison be-
tween this last result and the exact distribution of TM is visualized by Figure 2.5,
which highlights that the asymptotic approximation provided by Theorem 2.4.4
is extremely good for almost all values of M . Now, notice that since the random
variables X i in the statement of Theorem 2.4.4 are exponentially distributed, we
can scale out their parameters as we did to derive the Rényi representation of










where Xi ∼ Exp(j2i ) for every i. Hence, by joining this observation and Theo-








As noticed by Pakes [148], the distribution provided in Theorem 2.4.4 was first
investigated by Ciesielski and Taylor [42] in the context of diffusion limits for
branching processes.
We also stress that in the critical case the hitting time TM , conditioned on
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ΩM and Z0 = 1, is distributed like a sum of exponentials both for finite M and
in the asymptotic limit for M large. Hence, the asymptotic distribution of TM
conditioned on absorption in M and n0 > 1 initial individuals follows by adapt-
ing Proposition 2.3.2 to the parameters of the exponential random variables in
Theorem 2.4.4. The same reasoning applies to the noncritical case only when M
is finite, and not in the asymptotic regime.
Figure 2.5: Comparison between exact and asymptotic distributions of hit-
ting times in a critical branching birth-death process. The histograms in the
top panel show the distribution of the first passage time to M = 5, 10, 15, 20 obtained
from 105 simulations of a critical branching birth-death process with birth rate α = 0.15
day−1. In the same panel, solid lines represent the corresponding exact theoretical den-
sities computed from Proposition 2.3.4, while the dashed lines plot their asymptotic
limit derived from Theorem 2.4.4. The exact and asymptotic distributions are very
similar already for M = 5, and from M ≥ 10 they cannot be distinguished. The good-
ness of the approximation provided by the asymptotic results in the critical case is also
visualized in the two bottom panel, which show that the exact and asymptotic expres-
sions for the mean and variance of TM (see Proposition 2.3.5 and equation (A.8), and
equation (2.17) ,respectively) perfectly match each other.
Finally, the expression for the asymptotic mean of TM can be derived from
its exact forms given by Proposition 2.3.5. Looking also at the formula for the
exact variance provided in the appendix (see equation (A.8)), we find
E[TM | ΩM ] ∼
M
2α




The same results can be obtained again through the parameters of the exponential
random variables in Theorem 2.4.4. For this approach, sums of terms j−2pi for
p = 1, 2 are discussed for example in [175].
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2.4.3 Extreme value interpretation
In the previous section we showed that hitting times in noncritical branching
birth-death processes asymptotically follow an extreme value distribution. How-
ever, our derivations do not clarify why these random variables behave like an
extreme. In order to interpret such results, we will exploit an argument based on
reversed birth-death processes, that we therefore introduce next.
Let Zt be a branching birth-death process with birth rate α and death rate β.
The reversed (sometimes also called dual) process Z∗t is defined as a branching
birth-death process with rates swapped, i.e. with birth rate β and death rate α.
In the following we will add a superscript asterisk to the notations introduced so
far every time we need to refer to quantities related to the reversed process. In
particular, looking at Section 2.2.1, we denote
T ∗j = inf{t > 0 : Z∗t = j}
and
P∗i (·) = P(· | Z∗0 = i) ,
P∗i (·) = P(· | Z∗0 = i, Z∗s ≥ i for all s) ,
P∗ī (·) = P(· | Z
∗
0 = i, Z
∗
s ≤ i for all s) .
Noncritical case
Assume that Zt is a supercritical branching birth-death process with birth rate α
and death rate β. Let Z∗t be the reversed process - which is therefore subcritical -
and suppose that Z∗0 = M . The asymptotic distribution of the time to extinction
of Z∗t as M gets large has been extensively studied (see for example [147, 92, 67]).
In our notation, it is given by






where q = β/α and λ = α− β are the extinction probability and the net growth
rate of the original process Zt, respectively. We immediately notice that the
expression in equation (2.18) coincides with the asymptotic distribution of TM
conditional on ΩM and Z0 = 1, as given by equation (2.14). On the other hand,
we observe that by the branching property (see equation (1.2)), each of the initial




to get extinct, each of these M lineages need to die out. The time T ∗0 is thus
the maximum of the extinction times of independent and identically distributed
processes, which explains why it follows an extreme value distribution.
Motivated by these observations, we now investigate the identity between
equations (2.14) and (2.18). To this purpose, a key property is provided by the
following.
Lemma 2.4.5. For any birth-death process Zt and any i, j,
Pi+1(Tj+1 ≤ t) = Pj̄(Ti ≤ t) .
This result was first shown by Sumita [180] and it implies in particular that if we
consider a birth-death process starting with one individual and conditioned on
non extinction, its first passage time to M has the same distribution of the time
that an identical process starting with M − 1 individuals and conditioned on no
visits to M takes to get extinct. This argument can in turn be applied to prove
the next proposition.
Proposition 2.4.6. Let Zt be a supercritical branching birth-death process with
birth rate α and death rate β, and Z∗t be the reversed process. Then
P1(TM ≤ t) = P∗M−1(T
∗
0 ≤ t) .
Proof. Following the discussion at the end of Section 2.3.2, we find that
P1(TM ≤ t) = P∗1(T ∗M ≤ t) .
The statement then follows by directly applying Lemma 2.4.5.
In light of this result, we observe that the identity between equations (2.14)
and (2.18) is shown if we can prove that the asymptotic limit of P∗
M−1(T
∗
0 ≤ t) as
M gets large coincides with that of P∗M(T ∗0 ≤ t). To this purpose, we relate these
latter two distributions by decomposing the time to extinction for Z∗t starting
from M individuals as
P∗M(T ∗0 ≤ t) = P∗M(R∗M +X∗0 ≤ t) . (2.19)
Here R∗M = sup{t > 0 : Z∗t = M} is the last exit time from M and X∗0 denotes the
extinction time “left”. From the definition of R∗M it follows that the only possible
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transition after R∗M is from M to M − 1 and subsequently it is not possible to go
back to M . Therefore, the distribution of X∗0 is exactly given by P∗M−1(T
∗
0 ≤ t).
Lemma 2.4.7. Let R∗M be the last exit time from M defined above. Then, its
distribution conditional on M initial individuals goes to zero in probability as M
tends to ∞.
The proof of this Lemma can be found in Appendix A.4. Finally, by joining the
previous results we can prove the following.
Theorem 2.4.8. Let Zt be a branching birth-death process and let Z
∗
t be its
reversed process. Then, as M becomes large we have
P1(TM ≤ t) ∼ P∗M(T ∗0 ≤ t) .
Proof. Lemma 2.4.7, together with equation (2.19), implies that
P∗M(T ∗0 ≤ t) ∼ P∗M−1(T
∗
0 ≤ t) (2.20)
asymptotically for M large. The statement then follows from the result in Propo-
sition 2.4.6.
As mentioned at the beginning of this section, the asymptotic equivalence
between P1(TM ≤ t) and P∗M(T ∗0 ≤ t) provides insight on why the former follows
an extreme value type. Here, we stress again that the interpretation of T ∗0 like
a maximum of i.i.d. random variables is a direct consequence of the branching
property, and can also be noticed looking at equation (1.7). From the same equa-
tion we also see that the distribution of the time to extinction for the progenies
of each of the initial M individuals of Z∗t is equal to







To check that such a distribution belongs to the Gumbel domain of attraction,
we refer for example to Theorem 1.6.2 in [121].
Critical case
We now apply the same reversal argument described in the previous section to
the critical case. Let Zt be a critical branching birth-death process with rate α.
Following the exact same steps as before, we find that the distribution of the time
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to extinction for the reversed process Z∗t starting with M individuals can again
be expressed as
P∗M(T ∗0 ≤ t) = P∗M(R∗M +X∗0 ≤ t) , (2.21)
where R∗M is the last exit time from state M and X
∗
0 is a random variable whose
distribution coincides with P1(TM ≤ t). However, for a critical branching birth-
death process the last exit time R∗M does not go to zero in probability as M →∞.
In order to check this, let us first compute the asymptotic distribution of T ∗0
conditional on M initial individuals. This follows again from equation (1.7) and
is given by




























asM →∞, which tells us that T ∗0 belongs to the Fréchet domain of attraction (see
Section 1.2.2). Now, the distribution of T ∗0 conditioned on M initial individual
and its limit discussed above both have infinite mean [20, 117]. On the other
hand, the exact and asymptotic distribution of TM have finite expectation (see
Proposition 2.3.5), which implies that E∗M [R∗M ] =∞ for every M . Therefore, the
last return time R∗M does not tend to zero in probability. As a consequence, in the
critical case the reversed argument we presented does not relate the asymptotic
behaviours of P1(TM ≤ t) with distributions of an extreme value type.
2.5 Summary of results
In this chapter we have reviewed results concerning the probability distribution
of hitting times in branching birth-death processes. For general birth-death pro-
cesses with a reflecting boundary at the lower end of the state space, the exact
form of this distribution is provided by a famous theorem from Karlin and Mc-
Gregor. Such a theorem characterizes the distribution of the hitting time to M in
terms of the M non-zero eigenvalues of the birth-death process infinitesimal gen-
erator. For branching birth-death processes, this characterization can be applied
by conditioning on non-extinction, since in this case state 1 becomes a reflecting
boundary.
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The result from Karlin and McGregor is closely related to properties of the
orthogonal polynomials associated to a birth-death process. In particular, the
eigenvalues of the underlying infinitesimal generator can be expressed in terms of
the zeros of these polynomials. For critical branching processes, the associated
orthogonal polynomials are Laguerre ones with index 1, while for noncritical pro-
cesses they do not correspond to a known class.
For the biological applications that motivate this work, the asymptotic dis-
tributions of hitting times to a large size are of great interest. Using the results
for finite size, in the critical case we derived these distributions by exploiting the
asymptotic limit of the zeros of Laguerre polynomials. In the noncritical case we
had to use a different approach based on a classical martingale limit for branch-
ing processes. This argument showed that the hitting time to M in noncritical
branching processes asymptotically follow a Gumbel distribution as M gets large.
The last asymptotic limit highlights a non-trivial connection with extreme
value distributions, which we explored through reversed birth-death processes.
We showed that as M gets large, the time taken by a supercritical branching pro-
cess to go from size 1 to M is asymptotically distributed as the time to extinction
for a process starting with M − 1 individuals and with rates swapped. The latter
time is the maximum of the times to extinction for the progenies of each of the
initial individuals, and its distribution thus converges to an extreme value type.
The same reasoning does not apply to the critical process.
The results presented in this and in the previous chapter provide us with the
necessary tools to analyze our mathematical descriptions of cancer recurrence and
biomarker shedding. In particular, the asymptotic distributions of hitting times
in supercritical branching birth-death processes are fundamental to our model for
the time of cancer relapse that we will introduce in the next chapter.
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Chapter 3
Cancer recurrence times from a
branching process model
3.1 Introduction
Metastases develop as cancer cells disseminate from a primary tumor and es-
tablish new malignant lesions in the surrounding tissue or at other sites [168].
However, the full process of metastasis formation is much more complex and
many related aspects are not yet fully understood. In particular, it is still un-
clear whether metastases are initiated during early or late stages of carcinogenesis
(see e.g. [140, 81, 158]). These details, however, affect the chances of a patient
presenting detectable or undetectable metastases at diagnosis, which in turn in-
fluences treatment strategies and prognosis. For these reasons, different authors
(see e.g. [135, 77] and the references therein) have proposed mathematical models
to improve our understanding of the dynamics of metastasis formation.
Metastases frequently arise in cancer patients, and their occurrence greatly
diminishes the chances of effective treatment. In fact, even when a therapy is
initially successful, metastases often lead to relapse and are responsible for an
estimated 90% of cancer related deaths [36]. Despite this common disease pro-
gression, reliable predictions for cancer recurrence rates and times are still lacking
[189].
In Section 1.1 we have mentioned some of the many traits of tumor develop-
ment that have been described through the Luria-Delbrück model and its gener-
alizations. Around the 1950s, several researchers started to employ these mathe-
matical frameworks to study temporal features of cancer evolution. In this con-
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text, Armitage and Doll were the first to propose a stochastic model for the time
to tumor onset [17]. A few decades later authors began to investigate stochastic
models of tumor latency time. In particular, these works led to mathematical
descriptions of optimal schedules of cancer surveillance [80, 79], cure rates [190]
and cancer recurrence [211]. While this literature is based on different definitions
of the random time to cancer relapse, the end point for all these random variables
is the time to occurrence of a new tumor, and they are thus studied in the context
of survival analysis. An excellent review of these models is provided in the book
by Yakovlev and Tsodikov [212].
In this chapter we build a model for cancer recurrence by joining these two
approaches. In particular, we consider a deterministically growing tumor seed-
ing metastases at a rate depending on its size [113], and model the evolution of
each metastasis (or clone) as independent birth-death branching processes. A
similar setup was used by Lea and Coulson to mimic mutations occurring in a
growing bacterial population [120]. In our model though we interpret these mu-
tation events (from wild-type cells to mutants) as metastasis initiation events.
The distribution of mutant close sizes was studied with an exponentially grow-
ing wild-type population [106] and with more general wild-type growth function
[142]. Kendall [108] also allowed the wild-type population to grow stochastically,
but this extension left the mutant behavior unchanged for small initiation (mu-
tation) rates [110, 37]. Hence in our model we describe the size of the primary
tumor as a deterministic function (focussing on exponential and logistic growth
as examples), while allow the seeded metastases to grow according to birth-death
branching processes. Within this framework we study the time to cancer relapse,
defined as the interval between the primary onset and the first time that any
of the metastases reaches a fixed detectable size. Similar characterizations are
employed in the threshold models described in [212, 211].
Our mathematical model for the time to cancer recurrence relies on the use of
a deterministic function and of branching birth-death processes to describe the
growth of a primary tumor and metastases, respectively. To justify the former
assumption, let us anticipate that metastases typically arise when a primary tu-
mor is relatively large. Hence, even if we used a branching birth-death process
to model also the evolution of a primary tumor, by the time of the first metas-
tasis initiation this would already express an almost perfect exponential growth.
On the other hand, fluctuations around small primary tumor sizes could affect
the times of metastases initiation and relapse, measured from the primary onset.
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However, since the time of this onset cannot be observed in practice, cancer re-
currence is usually measured from the day of diagnosis or surgical resection of the
primary, when again the tumor is already large. Hence, results computed from
an estimated time of surgery with this fully stochastic framework would almost
coincide with the predictions provided by our model with a deterministic expo-
nential primary growth. The employment of branching processes to model the
evolution of metastases is based instead on the assumption that competition for
resources among cancer cells will likely occur only once the tumoral mass is large.
The rest of this chapter is organized as follows: In Section 3.2 we present in
detail our mathematical model of metastases initiation and growth, and derive
an explicit formula for the probability distribution of the time to relapse.
In Section 3.3 we include into the model the resection of the primary tu-
mor at a given time. This allows us to distinguish between synchronous and
metachronous metastases and to study the relapse time distribution conditioned
on different events of clinical interest.
In Section 3.4 we report parameter estimates for five different cancer types
(namely breast, colorectal, headneck, lung and prostate) and compare the corre-
sponding results yielded by our model with data collected from clinical literature.
Conclusions are presented in Section 3.5, while supplementary information are
shown in Appendix B.
3.2 Metastasis seeding and growth
Our mathematical characterization of the time to cancer recurrence is based on
a stochastic model of metastasis formation. Here we first present the fundamen-
tal assumptions and features of this model, and then use them to derive the
probability distribution of the time to relapse.
3.2.1 Model setup
We model the number of cells in the primary tumor as a deterministic function
of time n(t). The tumor initiates metastases at rate νn(t), where ν is constant.
Here we implicitly assume that all tumor cells can metastasize at the same rate.
Since we make no assumptions on n(t), one can define initiation at rate νn(t)γ
to model scenarios where only a fraction of the primary tumor can metastasize,
for example only the cells near its surface or close to blood vessels (see e.g. [77]).
The initiated metastases are then modelled as independent branching birth-death
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processes (see Section 1.2.1), all with the same birth rate α and death rate β. We
assume that they are supercritical, that is they have a positive net growth rate
λ = α − β > 0 and that cancer cells from metastases do not have the ability to
metastasize further [90].
Under these assumptions each metastasis will eventually go extinct with prob-
ability q = β/α < 1. The surviving ones instead grow unboundedly and will reach
any given size [20]. Let M be a fixed number of cells representing the minimal
detectable size of a cancerous lesion. Here we aim to describe the time to cancer
recurrence, defined as the first time τ that any of the surviving metastases reaches
the detectable size M .
The minimal detectable size M is typically very large, with estimates larger
than 106 (see Section 3.4.1). As the probability that a large supercritical popu-
lation goes extinct is negligibly small, we assume that each metastasis survives if
it reaches M . Then, due to the splitting property of Poisson processes, the sur-
viving metastases that eventually reach the detectable size are initiated as a non-
homogeneous Poisson process (Kt)t≥0 with rate ν(1 − q)n(t) (see Section 1.2.3).
Here Kt denotes the number of metastases initiated by t, conditioned on survival.
The expected number of established metastases at time t is thus




and the probability that at least one is present at t is equal to
P(Kt ≥ 1) = 1− e−at . (3.1)
Surviving metastases are initiated at times σi := inf{t ≥ 0 : Kt = i} and are
described by i.i.d. birth-death processes (Si(s))s≥0, where Si(s) is the number of
cells in the i-th metastasis at time s after its establishment. In particular, we
have Si(0) = 1 for every i. For each of these processes we can then define Θi :=
inf{s ≥ 0 : Si(s) = M} as the time needed by the i-th established metastasis
to grow to the detectable size M , counting again from its initiation. Since the
processes Si(s) are independent, the hitting times Θi are also independent and
identically distributed. As shown in Theorem 2.4.1, for large M these hitting
times asymptotically follows a Gumbel distribution. Hence, we have






∞ denotes the eventual survival for the ith metastasis. Notice that here-




; t), where the distribution
function G(a, b; t) of the Gumbel for the maximum is defined by equation (1.20).
3.2.2 Time to reach detectable size
Given the definitions in the previous section, we have that the i-th metastasis
reaches the detectable size at time τi := σi + Θi, measured from primary onset.
Metastases are initiated at time s at rate ν(1 − q)n(s) and then reach the de-
tectable size before t with probability G(t − s). Hence, the thinning property
of Poisson processes (see equation (1.22)) yields that metastases which become
detectable by time t are initiated at s at rate ν(1− q)n(s)G(t− s). The number
St of such metastases established by t is thus a Poisson random variable with
mean
bt = E[St] = ν(1− q)
∫ t
0
n(s)G(t− s)ds . (3.3)
The relapse time is defined as the first time any metastasis reach the detectable
size, τ := mini{τi}. Hence, τ is smaller than t if by that time at least one
metastasis that becomes detectable before t is initiated, and so
P(τ ≤ t) = P(St ≥ 1) = 1− e−bt . (3.4)
In the large detectable size M limit, the relapse time distribution converges to a





where the random variable τ̄ is distributed as








Hence for large M the relapse time decomposes as τ ≈ 1
λ
logM + τ into a deter-
ministic part which depends only on λ and M , and a random fluctuation described
by τ̄ . This decomposition also allows us to estimate the expected value of the
relapse time as E[τ ] ∼ 1
λ
logM +C where the constant C = E[τ̄ ] can be obtained
from equation (3.5).
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Figure 3.1: Relapse time densities for logistic and exponential primary
growths and different initiation rates. The probability densities shown, fτ (t) =
d
dt P(τ ≤ t), are computed from equation (3.4) with ν = 10
−10, 10−11, 10−12, 10−13, 10−14
from left to right. Using parameter estimates for colorectal cancer (see Table 3.2), the
logistic densities (dashed lines) converge to the corresponding exponential ones as the
initiation rate increases. Furthermore, in the exponential case and for all the above
values of ν, the densities derived from equation (3.4) and their approximation obtained
from equation (3.6) are indistinguishable.
3.2.3 Exponential population growth
Two commonly employed primary growth functions are the exponential and lo-
gistic ones. These are given by n(t) = eδt and n(t) = Ke
δt
K+eδt−1 , respectively, where
δ denotes the primary tumor net growth rate and K a carrying capacity. Relapse
time densities for these two growth types and different initiation rates are shown
in Figure 3.1. Here we observe that as ν increases, the logistic distributions con-
verge to the exponential ones (see Appendix B.2). Moreover, for all our parameter
estimates our model predicts the same results with these two growth types. The
reason is that the metastases determining the time to relapse are initiated during
the early phase of tumor evolution which is almost exponential even for a logistic
growth. Therefore, from now on we will focus on the results for an exponential pri-
mary growth. Also notice that if only a fraction n(t)γ of the primary tumor cells
can metastasize, for n(t) = eδt this would only affect the primary net growth rate.
Since the initiation rate ν is much smaller than all other parameters, here we
study in detail the most relevant case, that is the small ν limit for an exponentially




















The first parameter of this Gumbel distribution is proportional to log ν, which
explains the equal spacing between the densities in Figure 3.1 for logarithmically-
spaced values of the initiation rate. Also notice that such densities are left skewed,
as it is expected from the Gumbel for the minimum. On the other hand, the Gum-
bel for the maximum - which describes the fluctuations of the time to detection
starting from a single initial cell - is right skewed (see Section 1.2.2). How one
distribution changes to the other can be observed in Figure 3.3.
In the parameter regime considered here the mean relapse time is approxi-
mately given by





















As shown by Figure 3.2, this expression fits simulations even for relatively large
values of ν and small values of M .
Equation (3.7) highlights a simple dependence of the mean relapse time E[τ ]
on M and ν. In Appendix B.2 we also compute the mean time to detectability
of the first established metastasis, E[τ1], where τ1 = σ1 + Θ1 is equal to the sum
of the first initiation time and the hitting time to M . Interestingly E[τ1] has the
same M and ν dependence shown in equation (3.7), but the constant term C̃ is
different. For example, using the parameter estimates for colorectal cancer (see
Table 3.2) we find C ≈ 250 and C̃ ≈ 309. The reason for this difference is that
even in the small ν - large M limit, later established metastases can outrun the
earlier ones in reaching M first.
3.3 Primary tumor resection
Surgery is still the most common and effective type of treatment for solid tumors,
although often used in combination with other kind of therapies (see e.g. [28]).
However, how the time of resection affects prognosis, and in particular the esti-
mation of the time to relapse, is still unclear. In order to investigate this question
in a theoretical framework, we now embed surgery in our model and study how
it changes the distribution of the time τ to relapse.
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Figure 3.2: Relapse time distribution for exponential primary growth in the
small initiation rate - large detectable size limit. The figure is based on the
parameter estimates for colorectal cancer - see Table 3.2. On the left, each starred dot
denotes the mean of 1000 simulations, while lines represent the theoretical expectation
given by equation (3.7). These match the simulated means almost perfectly for most ν
values, as the fit becomes poor only for ν = 10−2 or greater. On the right, the relapse
time densities derived from equation (3.6) yield a bad approximation only for very
small values of M , as the simulated data (10000 simulations per curve) are matched
for M = 100 or higher.
3.3.1 Relapse time with resection
Let us assume that at a given moment after detection a primary solid tumor is
surgically removed. This event can be mathematically implemented in our model
by considering a resection time T such that n(t) ≡ 0 for t ≥ T . In particular, this
implies that after T no metastases can be initiated. The number of metastases
already established at resection is equal to KT , and their size distribution is given
in [142]. The distribution of the time τ to relapse can then be expressed exactly





n(s)ds < ∞, there is a positive probability that no metastasis
will ever occur (notice that from this point of view our framework can be seen as
a cure model - see e.g. [152]) and in this case we set τ =∞. The distribution of
the relapse time conditioned on at least one metastasis established by resection
is simply







This conditional distribution for different resection times is depicted in Figure 3.3.
In this and following figures, the resection time is shown at the bottom of the
figure, and the corresponding resection size N = eδT is shown on the top. As
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T → 0 all metastases have to be initiated close to time zero, so the relapse
time becomes the time to reach size M from a single cell, which has the Gumbel
distribution for the maximum given by equation (3.2). If we then increase the
resection time, the conditional densities shift to the right by the same amount.
Finally, as T → ∞ the relapse time distribution converges to the case without
resection
P(τ ≤ t | KT ≥ 1)→ P(τ ≤ t) .
The fluctuations for the unconditional distribution follow a Gumbel type for the
minimum, as per equation (3.6). Hence, as time increases, the relapse time dis-
tribution turns from a right-skewed Gumbel to a left-skewed Gumbel.
Note that the densities in Figure 3.3 become indistinguishable from the large
time limit as P(KT ≥ 1) approaches one. The reason is that by this time metas-
tases have probably already been initiated and one of the early established ones
is likely to relapse first. This suggests that only early enough resection times
change the behaviour of the model. For example in the case of colorectal cancer,
according to Figure 3.3, only resections of tumors smaller than 109 cells affect
the time to recurrence.
Right skewed densities are often chosen to fit probability distributions arising
in survival analysis. This is due to the fact that most survival data suffer from
right censoring [9], where only a lower bound is known for data points. Looking
at the densities in Figure 3.3, though, we can see both left and right skewed
distributions. While a few survival datasets are negatively skewed [133], cancer
relapse times are typically right censored as a consequence of limited follow-up
and patients decease before relapse (see e.g. [174]). However, our model does
not take into account any of these events. Furthermore [78] recently proposed
a model for the estimation of screening times for colorectal cancer based on the
observation that some datasets suffer from left censoring as well.
3.3.2 Metastasis classification
If the resection is successful and the primary tumor is completely removed, the
therapy can still fail due to the formation of metastases. For this reason, it is
common practice to start looking for detectable metastases several weeks before
the surgery. In this section we thus want to characterize the metastases which
are detectable at a given time and those which are not.
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Figure 3.3: Relapse time densities conditioned on at least one metastasis
initiated by the time of resection. For different values of the resection time T ,
marked with ticks of corresponding colors, the densities fτ (t | KT ≥ 1) are computed
by differentiating equation (3.8). As T becomes larger, the probability of metastases
established before resection (see equation (3.1)) increases and the conditional relapse
time densities converge to the red limit one. Here we have used parameter estimates
for colorectal cancer (see Table 3.2), n(t) = eδt and 7 equally spaced resection times
between 0.25y and 16.15y. The curves for T > 15y look identical to the limit density.
In general the metastasizing process (Kt)t≥0 can be split into two independent
Poisson processes (St)t≥0 and (Mt)t≥0 describing the initiation of metastases which
reach size M before or after t, respectively. Following the same argument we used
at the beginning of Section 3.2 we see that a mean number bt of metastases of
the former type are initiated by t. Therefore we get
St ∼ Pois (bt) , Mt ∼ Pois (ct) ,
where ct = at − bt. In particular, we have that the events {τ > t} and {St = 0}
are equivalent. We also stress that the definitions above naturally extend to the
case of a primary resection, by simply redefining n(t) to be zero after the resection
time T .
Now, despite an ongoing discussion on the following nomenclature (see e.g.
[4]), in the rest of the paper we will call a metastasis synchronous if it reaches
the detectable size M before or up to the time of resection, and metachronous
otherwise (hereby the choice of notation St and Mt). These characterizations
immediately allow to estimate the probability of clinically relevant events. For
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example, the probability of no synchronous metastases is equal to
P(ST = 0) = P(τ > T ) = e−bT . (3.9)
Also, under this condition, relapse is not certain: the probability that at least
one metastasis was initiated given that there are no visible ones at resection is
P (KT ≥ 1 | ST = 0) = P(MT ≥ 1) = 1− e−cT , (3.10)
since ST and MT are independent. In next section we will study the above and
related quantities in greater detail.
3.4 Comparison to data
In this section we compare the predictions provided by our model with clinical
data collected for different cancer types. To this purpose, we first need to estimate
the parameter values for each of these cancer types.
3.4.1 Parameter estimation
The net growth rates of the primary and metastatic tumors, δ and λ, are inferred
from the corresponding tumor volume doubling times (denoted DTpt and DTm,
respectively) as
δ = log 2/DTpt , λ = log 2/DTm .
These times have been studied by many authors, starting from the influential
papers of [43, 171, 177]. Many authors still refer to these early works, although
in some cases more recent estimates are available. Colorectal, breast and lung
cancers are the most frequently studied. Furthermore, more papers focus on
primary doubling times than on metastatic ones. Similarly, the birth rate α
is derived from the potential doubling time Tpot, defined as the time between
cell divisions in the absence of cell death [97]. In this case we simply use the
estimation
α = 1/Tpot .
As for the primary tumor size N at resection, many studies report data on the
primary maximum diameter, allowing for ellipsoidal forms. However, given the
relatively small tumor volume and the wide interpatient variability, we assume a
spherical shape and estimate dpt from the corresponding typical range. By also
assuming 109 cells per cm3, the primary size at resection (expressed in number





Table 3.1 summarizes typical ranges of these quantities for five different can-
cer types, together with our estimates and corresponding literature references.
Difficulties in distinguishing between primary and secondary tumors or in track-
ing down the primary origin of a metastatic cancer could in principle affect some
of these data, but the wide range and multiple references reported reduce the
potential impact of this effect.
Table 3.1: Typical ranges of tumor volume doubling times and tumor diam-







DTpt (days) 103− 353 210 [197, 118, 151, 167, 71, 218]
DTm (days) 85− 199 105 [119, 69]
Tpot (days) 8− 35 15 [82, 21]
dpt (cm) 1.4− 3 2.5cm [216, 122, 49]
Colorectal
DTpt (days) 130− 438 175 [27, 183, 39]
DTm (days) 45− 155 105 [64, 69, 185, 187]
Tpot (days) 3− 4 4 [209, 21]
dpt (cm) 3.5− 5.1 4.5cm [27, 116, 39, 52]
Headneck
DTpt (days) 15− 256 84 [198, 94]
DTm (days) 9.5− 320 56 [72, 192]
Tpot (days) 1− 14 4 [209, 217]
dpt (cm) 1.3− 4 2.8cm [138, 130]
Lung
DTpt (days) 22− 269 168 [109, 15, 69, 50, 86]
DTm (days) 32− 98 56 [177, 215]
Tpot (days) 2− 17.5 2.5 [109, 68]
dpt (cm) 1.7− 4.1 2cm [22, 178, 50]
Prostate
DTpt (days) 36− 1080 392 [46, 206, 220]
DTm (days) 29− 213 98 [24, 220]
Tpot (days) 15.2−97.8 34 [83, 206]
dpt (cm) 0.1− 2.9 1.2cm [159, 96]
Notice that by estimating the rates λ and α we also infer values for the death
rate β = α − λ and the extinction probability q = 1− λ/α. These estimates are
based on the assumption of an exponential primary growth, which can be relaxed
as in [184]. For the two remaining parameters, namely the initiation rate ν and
the minimal detectable size of a metastasis M , we use common estimates across
different cancer types. Various studies report a lowest detectable tumor diameter
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of 0.2cm for different cancer types (see e.g. [173, 70, 200]), corresponding to
M ≈ 4.19×106 cells. Moreover, several papers argue that the first metastases are
likely to establish long before the detection of the primary tumor (see for example
[69] and the references therein). In particular, the review of the progression
model for metastases formation in [113] reports that dissemination starts when
the primary diameter is between 0.1 and 0.4cm. Here, we thus consider the
primary tumor size at the expected time of the first metastasis initiation and
estimate it to be eδE[σ1] = 108 cells, corresponding to a diameter of about 0.58cm.





Finally, the carrying capacity for the logistic primary growth is set to K = 1012
[113, 38]. Overall, we thus found estimates for the following input vector
(DTpt, DTm, Tpot, dpt, dm, e
δE[σ1])
and used them as described above to derive values for our model parameters, i.e.
(δ, λ, ν, q,N,M) .
Such estimates are summarized in Table 3.2.
Table 3.2: Estimates for the model parameters. The primary tumor and metas-
tases net growth rates δ and λ and the initiation rate ν are measured in cells per day.
The typical resection and detection size, N and M respectively, are expressed instead
in number of cells. Finally, the estimated extinction probability q is a pure number.
Breast Colorectal Headneck Lung Prostate
δ 0.0033 0.0040 0.0083 0.0041 0.0018
λ 0.0066 0.0066 0.0124 0.0124 0.0071
ν 1.87× 10−10 8.42× 10−10 9.36× 10−10 7.49× 10−10 4.13× 10−11
q 0.9010 0.9736 0.9505 0.9691 0.7595
N 8.18× 109 4.77× 1010 1.15× 1010 4.19× 109 9.05× 108
M 4.19× 106 4.19× 106 4.19× 106 4.19× 106 4.19× 106
To conclude this section, let us mention that by employing branching birth-
death processes to model the evolution of metastases, we are implicitly assuming
that the lifespans of tumor cells are exponentially distributed. This assumption
was primarily made to keep the model simple and to be able to apply and test
the results presented in Chapter 2. However, while the duration of cell cycle is
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Figure 3.4: Hitting times with Gamma distributed cell cycle duration. The
figure shows a first passage time distribution for a stochastic process Z̃t, defined as a
process starting with one individual, jump probabilities equal to those of the branching





tribution. In particular, the histogram shows the distribution of the first passage time
to M = 100 obtained from 105 simulations of the process Z̃t. The red curve illustrates
instead the exact theoretical density of T100 for the branching-birth death process Zt,
derived from Theorem 2.3.1. Using our estimates values of α and β for colorectal can-
cer (see Table 3.2), and already for M = 100, the two models provide almost identical
results.
likely to follow more complicated distributions (see e.g. [137, 205]), we expect
that the shape of these distributions should not affect significantly our results,
provided that their mean and variance are approximate those of the exponential
interevent times. An intuitive explanation for this feature is that if a branching
birth-death process is sufficiently close to criticality - as it is the case for all our
estimates in Table 3.2 - then it takes on average a long time and a significant
number of jumps to reach even relatively small sizes, and differences in the shape
of cell lifespan distributions get lost across such a long time. As an example,
we have simulated the distribution of the first passage time to 100 cells for a






an assumption takes into consideration the three phases of a cell cycle described
in [205], while the expected cycle duration is the same as for the branching birth-
death model. These simulations are shown in Figure 3.4, and already for M = 100
they are perfectly matched by the theoretical density of T100 computed from
Theorem 2.3.1. While this suggests that our predictions based on a branching
process model are realistic, we aim to investigate further the effect of alternative
cell lifespan distributions in a future study.
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3.4.2 Model predictions
By employing the parameter estimates reported in Table 3.2 we can analyze the
















































probability of synchronous metastases
high-risk interval
Figure 3.5: Probability of extant and synchronous metastases. These proba-
bilities P(KT ≥ 1) - dashed curve computed from equation (3.1) - and P(ST ≥ 1) - solid
curve computed from equation (3.4) - are plotted as functions of the resection time T for
five different cancer types. The primary tumor size at resection is N = eδT and thus de-
pends on the primary net growth rate. These resection sizes are discussed Table 3.3. For
each cancer type, the shaded areas highlight resection time intervals leading to a probabil-
ity higher than 85% of established and all undetectable metastases. Using the parameter
estimates from Table 3.2, the width of these intervals is 3.41, 3.17, 1.92, 0.94, 1.19 years
for breast, colorectal, headneck, lung and prostate cancer respectively.
Let us start by the simplest predictions of the model, which are about the pres-
ence of synchronous and metachronous metastases. Figure 3.5 shows the proba-
bility of initiated metastasis by resection P(KT ≥ 1) = 1− e−aT (equation (3.1)),
and that of synchronous metastasis P(ST ≥ 1) = 1 − e−bT equation (3.4)) as
functions of the resection time, for five different cancer types. Clearly, metas-
tases establish much before any of them becomes visible. For all five cancer types
considered, one or more metastases have likely been initiated by the time the pri-
mary tumor reaches about 8.2× 108 cells (diameter 1.16cm). While this value is
similar across different primary types (as a consequence of the parameters estima-
tion procedure, see Section 3.4.1), the results for the probability of synchronous
metastases vary widely. For breast, colorectal, headneck, lung and prostate can-
cer, Table 3.3 reports primary tumor sizes at which synchronous metastases might
start to appear and are likely to be present, respectively (expressed both in terms
of number of cells and tumor diameter). By comparing these values to typical
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Table 3.3: Resection sizes of the primary tumor which yield low and high
probability of synchronous metastases, respectively. For each cancer type con-
sidered, these sizes are computed with the parameter values in Table 3.2 and expressed
both in terms of number of cells, N , and tumor diameter, d.
Breast Colorectal Headneck Lung Prostate
P(ST≥1)>0.01
N 1.32× 109 2.13× 109 7.03× 109 1.03× 108 6.27× 107
d 1.36 1.60 2.38 0.58 0.49
P(ST≥1)>0.99
N 6.03×1011 9.88×1011 3.22×1012 4.65×1010 2.89×1010
d 10.48 12.36 18.32 4.46 3.81
resection sizes in Table 3.1, we find that detecting metastases at resection is very
likely for lung and prostate cancer and rare for headneck primary tumors.
One of the most challenging scenarios for the development of an effective treat-
ment is when there are only undetectable metastases present. In our framework
this scenario corresponds to the event
UT := {KT ≥ 1, ST = 0} ,
which has probability (see equations (3.9) and (3.10))
P(UT ) = P(MT ≥ 1, ST = 0) = P(MT ≥ 1)P(ST = 0)
= e−bT − e−aT = P(KT ≥ 1)− P(ST ≥ 1) .
(3.11)
Because of the last identity, the probability of established and all metachronous
metastases can be read out from Figure 3.5 as the difference of the two curves.
There, the shaded areas highlight intervals of resection times yielding P(UT ) >
85%. These intervals, often referred to as high-risk period, are alarmingly wide,
especially for breast, colorectal and headneck cancers. Furthermore, the esti-
mated resection sizes given in Table 3.1 fall within or close to these ranges (P(UT )
equal to 93.87%, 79.83%, 98.35%, 66.04% and 85.85% for the five primary tumor
types studied, respectively).
In order to check the robustness of this feature, we analyze it for a range
of parameters values. In particular, Figure 3.6 shows the probability of UT for
different values of the primary net growth rate δ and of the initiation rate ν,
focussing on the parameter estimates for colorectal cancer. The width of the
high risk interval is constant with respect to ν, and shrinks only as the ratio
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Figure 3.6: Probability of established and all metachronous metastases. The
probability P(UT ) - as given by equation (3.11) - is plotted as a function of T and δ
(left panel) and T and ν (right panel). The parameter estimates used are those for
colorectal cancer reported in Table 3.2. The plots show that the width of the high-risk
interval - the range of resection times such that P(UT ) is high - stays roughly constant
for most parameter values. This width (about 3 years) shrinks only for metastases
growing significantly faster than the primary tumor that initiated them.
between the primary and metastatic net growth rate becomes very small. The
same qualitative behaviour can be obtained with the parameter estimates for the
other cancer types. As most metastases grow up to two times faster than the
primary tumor they originated from [113], our model suggests that for a wide
choice of parameters there is a substantial range of resection sizes that lead to a
high probability of established and all undetectable metastases.
Next, we ask how such a probability, P(UT ), influences the time to cancer
recurrence. The conditional distribution of the relapse time τ becomes




for t ≥ T . From this distribution we compute the expected relapse time after
resection and conditioned on UT , E[τ − T | UT ]. This expectation and the prob-
ability P(UT ) are plotted in Figure 3.7. We see that for resection sizes smaller
than 108 cells the relapse occurs on average between 4 and 5 years after resec-
tion, otherwise independently of the primary size. For resection sizes around 108
cells undetectable metastases become likely, and E[τ − T | UT ] starts to decrease
with tumor size. Then, at about 19 years the probability of only undetectable
metastases present and the conditional mean relapse time both approach zero.
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Figure 3.7: Expected relapse time measured from resection, conditioned on
extant but all undetectable metastases. The dashed line and the light blue shaded
area show P(UT ) and how spread is the conditional relapse time distribution, respec-
tively, while the solid blue curve represents E[τ − T | UT ]. The parameter estimates
used are those for colorectal cancer reported in Table 3.2. For resection times close to
zero this conditional expectation coincides with that of the Gumbel distribution given by
equation (2.14), at about 5 years. As T starts to increase E[τ−T | UT ] reflects the con-
vergence highlighted for Figure 3.3, first slightly decreasing and then staying constant
around 4.4 years. Finally, when the resection time falls into the high-risk window, the
expected relapse time drops to zero. This suggests that the bigger the primary tumor
size is at resection, the faster relapse will occur.
Using the values from Table 3.2 we then tested our model by computing the
probability of synchronous metastases and the mean relapse time conditioned on
established but all undetectable metastases. The predictions from our model,
typical ranges and references for each cancer type considered are summarized in
Table 3.4. Here, notice that our predictions for the mean relapse time fall on the
lower end of the respective typical ranges. This is expected since we compute the
time to recurrence τ based on the minimal detectable size M , while in practice
metastases are often detected only at larger sizes.
In general, for different cancer types it is observed that metastases can grow
up to 2 times faster than the primary tumor they originated from [113], although
values as high as 4 has been proposed [123]. Our estimates fall within this range
(δ/λ = 4 for prostate cancer, 3 for lung and between 1.5 and 2 for the others). As
per the time interval from primary onset to surgery, the typical range is 15− 25
years [97]. Here, the high variability in our estimates of DTpt make T fall outside
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Table 3.4: Typical ranges for the probability of synchronous metastases and
the expected relapse time after resection, their predicted values from the
model and literature references for each cancer type. P(ST ≥ 1) is a pure










P(ST ≥ 1) 5− 10 6.13 [12, 30, 213]
E[τ−T | UT ] 590− 1022 725 [111, 65, 145]
Colorectal
P(ST ≥ 1) 15− 25 20.17 [107, 149, 128, 56, 88, 213]
E[τ−T | UT ] 353− 760 356 [87, 143, 56, 179, 88]
Headneck
P(ST ≥ 1) 1− 16.8 1.65 [62, 93]
E[τ−T | UT ] 219− 623 435 [126, 55, 207]
Lung
P(ST ≥ 1) 30− 55.39 33.96 [213, 191]
E[τ−T | UT ] 210− 602 249 [7, 89, 60]
Prostate
P(ST ≥ 1) 10− 34 13.53 [115, 66, 10]
E[τ−T | UT ] 730− 1131 969 [29, 188]
that range for headneck (T = 7.69y), lung (T = 14.71y) and prostate (T = 32y)
cancers, classifying the first two as fast growing tumors and the latter as a slow
growing one. The singular features that the model predicts for prostate cancer
are in accordance with clinical studies (see e.g. [170, 24]).
The last trait of cancer recurrence that we are going to examine is disease-
free rates. These generally correspond to the survival function of the relapse
time, P(τ > t). However, following the previous discussion we will condition this
probability on no synchronous metastases, obtaining
P(τ ≤ t | ST = 0) = 1− e−(bt−bT ) , (3.12)
for t ≥ T . In this case we do not observe any convergence to the density without
resection, because if T → 0 then no metastasis can be initiated and if T → ∞
the condition ST = 0 pushes the relapse time to infinity. Here let us also stress
that our model does not provide information on survival rates, as no modelling
of the time to decease is incorporated. Furthermore, notice that P (τ > t) yields
a good description of the disease-free rates in terms of metastases detectability,
but not necessarily with respect to cancer symptomaticity.
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Figure 3.8: Disease-free curves for different resection times. The earlier the
primary tumor is resected the higher is the probability that no metastases will arise,
or cure probability, represented by the value of the final plateaus. The resection times
are chosen so that P(KT = 0) = 0.75, 0.6, 0.45, 0.3, 0.15, 0.001 respectively. With the
parameter estimates for colorectal cancer (see Table 3.2) these times range from 12.28
to 14.48 years, corresponding to sizes between 5.12× 107 and 1.23× 109 cells (diameter
0.46− 1.33cm), respectively.
The distribution P(τ > t | τ > T ) for different resection times is shown in Fig-
ure 3.8, studying again the case of colorectal cancer. As we are not conditioning
on at least one metastasis being initiated, there is always a positive probability
that relapse will not occur, that is τ =∞. The resection times are thus chosen so
to yield cure probabilities - P(KT = 0), corresponding to the final plateaus - equal
to 0.75, 0.6, 0.45, 0.3, 0.15 and 0.001, respectively. These times span across a total
range of about 2.2 years. Furthermore, excluding the latest resection time con-
sidered, the difference between two consecutive of these T values is between 0.28
and 0.4 years. Hence, our model suggests that delays of the order of months in
the time of primary resection lead to a significant decrease in the cure probability.
3.5 Discussion
We introduced a model of metastasis formation where metastases are initiated at
a time dependent rate, in the simplest case proportional to the size of a growing
primary tumor. All initiated metastases then evolve as independent supercritical
branching processes. Parameters of the model were estimated for five different
cancer types from the clinical literature. We studied the relapse time τ , that is
the earliest time when any of the metastases becomes detectable. We obtained
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the distribution of τ for a general primary tumor growth and focussed in particu-
lar on logistic and exponential growth functions. For clinically relevant initiation
rates the metastases which relapse first are typically initiated in the early phase
of the primary tumor development, which is exponential for both growth func-
tions considered. Hence the distribution of τ for exponential and logistic primary
growths is practically identical unless the initiation rate is unrealistically small
(ν ≈ 10−13 or smaller) and we can thus exploit the much simpler formulas for the
exponentially growing tumor.
We model the resection of the primary tumor by introducing a cut-off for
the growth function n(t). If metastases are likely already established at surgery,
their time of relapse is not influenced by the resection timing. We categorized
all metastases into synchronous and metachronous and computed corresponding
occurrence probabilities. With our estimated parameters we found that the prob-
ability of synchronous metastases and the mean relapse time after resection falls
in the typical clinical range for all five different cancer types we study.
A challenging scenario for treatment is that of patients with established but
all undetectable metastases. For all five cancer types we considered, the prob-
ability of this event is high within an alarmingly large range of resection sizes.
Unfortunately, the typical size of a resected tumor falls in or near this range for
all cancer types. The width of such a high-risk range is stable for varying values
of the initiation rate ν and the primary net growth rate δ. While conditioned
on the presence of initiated but all undetectable metastases, later resection times
lead to faster relapse after T . Relatively small delays in these resection times also
cause significant decrease in the cure probability. Within our model, surgery only
prevents recurrence if it is done before the onset of the first surviving metastases,
and we provided estimates for the primary tumor sizes at this onset time.
The parameter estimates summarized in Table 3.2 yield realistic predictions
for several quantities of clinical interest. Although in principle we can explore our
model predictions across the whole range of parameters, this would often lead to
unrealistic outcomes. In this sense the quantitative predictions of our model are
quite sensitive to the parameter values, but we have been able to find a combina-
tion of parameters that yields realistic results. On the other hand, the qualitative
features of our model are more robust to parameter changes, as demonstrated for
example in Figure 3.6.
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Metastases are seeded and establish colonies via a specific and complex pro-
cess called metastatic cascade (for details see e.g. [146]). Since this is known to be
a multi-stage process, some authors (see for example [53, 77, 76] and references
therein) have described metastases initiation through two-type stochastic mod-
els, where a cell needs to gain the ability to metastasize before it can establish
a new metastatic lesion. We did not choose that route for several reasons: (i)
the precise details of how and when cells reach the ability to metastasize are not
clear [97, 210], (ii) in our model we can think of n(t) as the number of cells which
can metastasize and so tailor the two approaches, and (iii) if we assume that
an acquired metastatic ability lowers the primary net growth rate, a branching
process model would predict the same exponential growth for the cells with this
ability [37], and hence this would only change the estimate of the initiation rate
in our model.
We did not include into our model a mechanism for metastasis seeding other
metastasis, although this phenomena has been observed in clinical studies [75].
The main reason for this omission was the lack of reliable data for the estimation
of the secondary seeding rate. By assuming the same primary and secondary seed-
ing rates, however, we would expect metastases to initiate secondary ones when
they reach around 108 cells, at which size they are already detectable. Hence, by
considering this scenario our predictions for the time to cancer relapse would not
change.
We aim to compare our model in the future to data where relapse times are
given jointly with primary tumor sizes at resection. Tumor size is of course not the
only relevant factor in predicting relapse times, so the model should be extended
to involve other features like a measure of malignancy perhaps, as in [31]. Many of
the parameters of the model can differ between patients, and also between each
metastasis. Therefore, including a probability distribution for the parameters
could also make our model more realistic, provided that such distributions can
be estimated from data. Furthermore, as we stressed at the end of the parameter
estimation section, we could consider alterative distributions for the cell cycle
duration and quantify precisely their effects on the predictions of our model.
Other possible extensions could include interactions among metastatic cells and
among metastatic lesions, effects of the immune system, allowing metastases to
seed other metastases, and providing an estimate for the fraction of cells which
can metastasize, perhaps through modelling angiogenesis.
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Chapter 4
Stochastic models of ctDNA
shedding
4.1 Introduction
Among the results discussed in Chapter 3, our model of cancer recurrence sug-
gested that early resection of a primary tumor decreases the probability of a
patient developing metastases and thus improves cure rates. In general, it has
been long known that the early detection of cancer can lead to better prognosis
and lower the costs related to the management of the disease [58]. For this reason,
significant research efforts have been dedicated to the enhancement of screening
and diagnostic techniques.
However, some of the standard approaches currently available present limita-
tions that are difficult to overcome. Modern imaging modalities based on positron
emission or computed tomography and magnetic resonance scans can detect tu-
mors as small as 7mm in diameter [57]. While such a lower detection limit is
bound to decrease with the advancements of these technologies, it is hard to pre-
dict if and when they will allow to detect cancer before the onset of symptoms or
the establishment of secondary tumors. Furthermore, once a tumor has been de-
tected, tissue biopsies are often performed to determine some of its biological and
genetic features. These procedures are often costly and invasive for the patient.
Moreover, it might be impossible to collect samples from some tumors, and even
when tissue biopsies are feasible they cannot be repeated over time.
Recently, the development of new screening tests based on the analysis of
bodily fluids spurred new hope for early cancer detection [125, 84, 85]. These
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tests, collectively referred to as liquid biopsies, search a patient blood sample for
specific biomarkers whose concentration and genetic composition can provide in-
formation about the presence of a tumor and some of its attributes. Compared to
solid biopsies, liquid biopsies are a minimally invasive test which can drastically
reduce the impact and costs of screening for patients. Furthermore, they offer
the opportunity for repeated tests that could potentially allow to monitor the
development of the disease over time.
Transforming liquid biopsies into a standard diagnostic routine also presents
many challenges (see e.g. [34]). For example, the level of biomarker in blood
samples from cancer patients might be extremely low, and can thus be detected
only by technologies with high sensitivity and sensibility. Furthermore, even if
the biomarker is detected and analyzed successfully, the correlation between its
properties and cancer features such as the tumor burden, localization, or stage
need to be quantified precisely.
When a cell dies it can release small fragments of DNA that start to circulate
independently in the bloodstream and are thus called cell-free DNA (cfDNA).
If the cell is malignant, the shed fragments will carry some of the tumor mu-
tations and are then referred to as circulating tumor DNA. Circulating tumor
DNA (ctDNA) is one of the most commonly employed cancer biomarkers in stud-
ies on liquid biopsies, together with circulating tumor cells (CTCs) and exosomes
[219, 153, 141]. In this chapter we introduce a fully stochastic model of biomarker
shedding and apply it in particular to ctDNA. Intuitively, if a patient has a bigger
tumor, a higher number of cancerous cells undergo apoptosis per unity of time
and so we would expect increased levels of ctDNA in the blood. The main aim
of our model is to provide a mechanistic description of the dynamics of cancer
growth and ctDNA shedding that helps to quantify the correlation between tu-
mor burden and ctDNA concentration.
The rest of this chapter is organized as follows. In Section 4.2 we introduce
our stochastic model for tumor growth ctDNA shedding. This first setup is based
on the assumption that ctDNA shedding occurs exclusively at cell apoptosis.
Throughout the chapter we apply our model to lung cancer, and estimates for
our model parameters in this case are presented here.
Next, in Section 4.3 we derive the probability distribution of the level of ctDNA
in the bloodstream when the primary tumor is made of M cells. Even if the
primary tumor is detected very early, it is still made of tens of thousands of cells,
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and we thus compute these distributions in the asymptotic limit for large M .
In Section 4.4 we then relax some of our assumptions and present a more general
framework that can be applied to different contexts. Specifically, we discuss the
scenario where a biomarker is shed not only at cell apoptosis but also at prolifer-
ation or per unit of time. Furthermore, for other applications asymptotic results
for large times, or simply the exact probability distributions of the processes in-
volved, might be of interest and we thus derive them here.
Finally, Section 4.5 presents conclusive remarks.
4.2 Model setup
Our setup is illustrated by Figure 4.1, that can thus be used as a reference.
We model the dynamics of tumor growth and biomarker shedding through a
continuous-time multi-type branching process [20, 112, 23, 11, 53]. The primary
tumor grows stochastically from a single malignant cell at time t = 0. The tumor
size at time t, denoted At and expressed in number of cells, is modelled by a su-
percritical branching birth-death process with net growth rate λA = αA−βA > 0,
where αA and βA denote the birth and death rate per day, respectively. Adapting
the notation and results in Section 1.2.1, we see that this process has a probabil-
ity qA = βA/αA to get extinct. Since we are only interested in primary tumors
that do not go extinct, we condition At on eventual survival, i.e. on the event
ΩA∞ := {At > 0 for all t}. Each cancer cell releases biomarker molecules into the
bloodstream at rate νA per day. In this setup we assume that the biomarker
is exclusively shed by cells undergoing apoptosis and hence the shedding rate is
given by νA = βA · µA where µA denotes the shedding probability per cell death.
Normal cells can also shed the biomarker into the bloodstream, as cells in
benign tumors and expanded subclones often acquire the same cancer-associated
mutations as cancer cells [131, 129, 186, 214]. We define Bt as the size of the
benign population of cells alive at time t and shedding the same biomarker as
cancer cells. We assume that healthy cells divide and die at the same rate βB,
and that the process Bt stays constant over time (Bt = B0 for all t). Hence, each
healthy cell sheds biomarker molecules into the bloodstream at rate νB = βB ·µB
per day, where µB denotes the shedding probability per cell death. Hereafter we
will assume that the shedding probabilities of cancer and normal cells are equal,
i.e. µA = µB = µ. Nevertheless, we expect the shedding rate νB to be lower than
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Figure 4.1: Evolutionary dynamics of ctDNA shed by benign and malignant
tumors. A | Normal cells release cell-free DNA (cfDNA) into the blood stream. Cells
from benign and malignant tumors shed cell-free circulating tumor DNA (ctDNA) into
the blood stream. B | Tumor cells divide with birth rate αA and die with death rate βA
per day. During cell apoptosis, cells release ctDNA into the vasculature with probability
µ. ctDNA is eliminated from the blood stream with rate ε per day according to the half-
life time of ctDNA t1/2. C | A benign lesion replicates with the same birth and death
rates per day, αB = βB. A primary tumor starts to grow at time zero with net growth
rate λA = αA − βA. Both lesions shed ctDNA into the blood stream according to the
product of their cell death rate and the shedding probability µ. D | Distribution of ctDNA
whole genome equivalents shed by the benign lesion and the primary tumor at the time
when the tumor reaches a size of 1 cm3 (≈ 1 billion cells). E | Probability distribution
of ctDNA whole genome equivalents shed by the benign lesion and the primary tumor
present in a liquid biopsy of 15 ml blood (7.5 ml plasma) at the time when the tumor
reaches a size of 1 cm3. The parameter values used are obtained in Section 4.2.1.
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The number of biomarker molecules in the bloodstream at time t shed by can-
cer and healthy cells is denoted by CAt and C
B
t , respectively. The total amount of




t . Biomarker molecules are eliminated
from the bloodstream at a rate ε which can be calculated from the biomarker
half-life time t1/2 as ε = log(2)/t1/2.
Because cancer and healthy cells shed biomarker molecules independently
from each other, the processes (At, C
A
t ) and (Bt, C
B
t ) can be studied separately.
The stochastic process (At, C
A
t ) is a two-type branching process governed by the
following transitions
A −→ AA rate αA ,
A −→ C rate βA · µ ,
A −→ ∅ rate βA (1− µ) ,
C −→ ∅ rate ε .








Since the healthy cell population Bt remains instead constant over time, C
B
t
is described by a pure death process with constant immigration (see again Sec-
tion 1.2.1). We assume that CBt is in equilibrium at time t = 0. Additional
details about this process, including the exact form of CB0 , will be presented in
next section.
4.2.1 Parameter estimation
Before we discuss further mathematical features of our model, here we provide
the parameter estimates for lung cancer that we will employ in this chapter (un-
less otherwise specified). These estimates are relative to the shedding of ctDNA
fragments by cancerous (At) and healthy or pre-malignant (Bt) cell populations.
The majority of parameters involved are rates, measured in cells/day. In the cur-
rent setting, both the processes At and Bt shed the biomarker at a rate given by
their cell death rate times the shedding probability (νA = βA · µ and νB = βB · µ,
respectively). Other parameters are simply measured in number of cells (initial
conditions for the three processes involved) or are pure numbers (shedding prob-
ability).
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For the birth rate of cancerous cells we use the estimate provided by [33, 32],




between 0.72 and 0.99. We estimate βA = 0.245, corresponding to qA ≈ 0.98.
We assume that the size of the healthy cells population remains constant
over time. Based on the values provided by [182] for polyp diameter, we set
B0 = 3× 108. Furthermore, in order to estimate how often this healthy popula-
tion sheds ctDNA, we need a measure of its turnover rate. Based on the values
indicated by [124], we set αB = βB = 0.1.
As for ctDNA elimination rate ε, [199] reports values of ctDNA halftime in the
bloodstream, t1/2, ranging between 16 and 150 minutes. We employ the estimate
t1/2 = 30 minutes, corresponding to ε =
log(2)
t1/2
≈ 33.27 ctDNA fragments per day.
Next we need to estimate the shedding probability qA, which in turn deter-
mines the shedding rates νA and νB. We assume that the shedding probability
µ is independent of cancer type. Bidard et al. [25] reported a count of 1 copy of
ctDNA shed per cm3 of metastatic uveal melanoma per ml of plasma. Similarly,
Parkinson et al. [150] estimated 6 ctDNA copies in high-grade serous ovarian car-
cinoma and Abbosh et al. [2] estimated 0.12 ctDNA copies shed per per cm3 of
non-small cell lung cancer (NSCLC) per ml of plasma (increase of 0.008% in VAF
per cm3, assuming 3000 whole genome equivalents per ml of plasma in healthy
subjects) [199, 63]. Since the NSCLC cohort was mostly composed of stage I and
stage II cancers while the cancers in the other cohorts were at stage III or IV,
we used the reported estimate in the NSCLC cohort. The value inferred from a
cohort of early stage cancers has indeed lower chances to be affected by unde-
tected metastases, that as discussed in Chapter 3 are more likely present at later
primary stages and can greatly increase the total tumor burden. Assuming an
average patient has roughly 6 liters of blood and that half of it is plasma, the
conservative estimate of 0.12 ctDNA whole genome equivalents per ml of plasma
shed per cm3 of tumor volume leads to 360 (= 0.12 ·3000) copies of ctDNA in the
whole plasma. As 1 cm3 of tumor volume contains 109 cells, we can then setup
the equilibrium equation
νNSCLC · 109 = 360 · ε
which leads to a shedding rate of νNSCLC ≈ 1.198 × 10−5 per cell per day. Be-
cause ctDNA shedding largely occurs during cell apoptosis [84] and lung cancer
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cells have been measured to die every ≈ 7 days [163], we find that the shedding
probability is µ = νNSCLC/βNSCLC ≈ 8.38× 10−5 per cell death.
To calculate the shedding rate of cells of other cancer types or tissues, we can
now simply rescale the shedding probability by the corresponding cell death rate
of these cells. For example, we estimate the shedding rate of benign cells by
νB = βB · µ.
To conclude this section let us stress that the parameters inferred above must
be interpreted as typical values for the corresponding biological quantities. While
the results presented in the following are based on these estimates, in prospect
we aim to refine such inference - as more data become available - and possibly to
derive a probability distribution for the parameter values. Finally, for a discussion
of the sensitivity of our model to these values we refer to the later Section 4.3.4,
and in particular to Figure 4.2.
4.3 ctDNA level distributions
The processes At, Bt and Ct are indexed by the time parameter t, where t = 0
at the primary tumor onset. In practical situations this time is impossible to
measure, and it is thus convenient to express the previous processes in terms of
other indexing parameters. In our case a suitable choice is to use the first passage
time
TM := inf{t > 0 : At = M} .




CBTM express ctDNA levels in terms of an observable quantity, i.e. the primary
tumor size. Moreover, we are especially interested in our model predictions for
relatively large primary tumor sizes. When M is large and the shedding rate is




that greatly simplify computations and help getting insight into the
main evolutionary features of the model. In the following we thus focus on these
results first. Later we will generalize our model to include multiple biomarker
shedding dynamics and derive the probability distribution of the processes At, Bt
and Ct indexed by time.
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4.3.1 ctDNA shed by cancerous cells
The asymptotic behaviour of CATM in the small shedding rate - large primary
tumor size limit can be derived from referring to [37]. Adapting the results
presented there, we first observe that ctDNA fragments are shed by cancer cells
at a stochastic rate which is proportional to the primary tumor size, i.e. as a Cox
process with intensity (νAAt)t≥0 (see Section 1.2.3). For large times the branching





Here, we recall thatWA is a non-negative random variable such thatWA = 0 if and
only if the process At goes extinct. Using these properties and the definition of
TM , one can prove that in the small νA - large M limit and conditioning on Ω
A
∞ =
{W > 0} the number of ctDNA fragments shed by At up to time TM converges in
distribution to a Poisson random variable with rate νAM
λA
. Furthermore, as the age
and the lifespan of a randomly selected fragment are Exp(λA) and Exp(ε) random
variables respectively, the probability that any of the shed ones is still present
in the bloodstream at time TM is
λA
ε+λA
. Hence, due to the thinning property of
Poisson processes (see equation (1.22)) we find that for large primary tumor size







4.3.2 ctDNA shed by healthy cells
As mentioned in the previous section, if Bt is constant over time the process
CBt is a branching pure death process with immigration, with death rate ε and
immigration rate B0νB = B0βBµ. The probability generating function for such
a process thus follows from equation (1.15) by taking the limit for the birth rate
that tends to zero
CB(y, t) =
(
1 + (y − 1)e−εt
)CB0 e νBε B0(y−1)(1−e−εt) . (4.3)
Now, conditioning on At survival we have that limM→∞ TM = ∞ almost surely.
Hence, as the process (Bt, C
B













independently of the initial number of ctDNA fragments. The right hand side
in the last equation is the probability generating function of a Poisson random
variable with mean νB
ε













4.3.3 Total ctDNA levels and sampling
By joining the previous results we find the asymptotic distribution for the total
amount of ctDNA present in the bloodstream when the primary tumor is made of














Now, suppose that a blood sample of volume Vs is taken from a patient with
a total blood volume equal to Vtot. Assuming that the extant ctDNA fragments
are well mixed in the bloodstream, we approximate that each of them is present
in the sample with probability p = Vs/Vtot. Hence, by denoting Xt the number
of fragments in the sample at time t, we can apply again the thinning property












4.3.4 ctDNA shedding dynamics for lung cancer
We now discuss some quantitative and qualitative features of our model by ap-
plying the estimates for lung cancer to the results we derived in the previous
section. Using such estimates (obtained in Section 4.2.1), Figure 4.2 highlights
the dependencies of ctDNA levels on different parameters.
Our model predicts that smaller tumors lead to lower levels of ctDNA in the
bloodstream. We estimate that tumors with 300 million cells and a billion cells
(≈ 0.3 cm3 and ≈ 1 cm3) correspond to around 200 and 650 ctDNA fragments
present, respectively (Figure 4.2A). On the other hand, among two cancers of
the same size, the more aggressive one also leads to lower levels of ctDNA (Fig-
ure 4.2B) because fewer cell deaths decrease the amount of released biomarker.




















Figure 4.2: Tumor growth rate and cell turnover strongly affect the amount
of ctDNA. Top panels (A-C) depict the number of ctDNA fragments present in 3
liters of plasma at a given tumor size. Bars illustrate the distribution of ctDNA levels
based on 104 simulations. Full lines plot instead the asymptotic results derived from
equation (4.5), which perfectly agree with simulation results. Bottom panels (D-F)
show the simulated distribution of the number of ctDNA fragments present in 7.5 ml of
plasma, corresponding to a standard 15 ml liquid biopsy.
of ctDNA at a given tumor size (1 billion cells in Figure 4.2C) compared to lower
cell turnover rates.
These features reflect on the distributions of ctDNA levels in plasma sam-
ples. Panels D-F in Figure 4.2 show the probability densities derived from equa-
tion (4.6) for a blood sample of 15 ml taken at the time when the tumors reach
the given sizes. From these plots we observe that the tumor size has the highest
impact on the expected number of ctDNA fragments present in the sample. In
fact, for all tumors made of a billion cells this expected value is higher than or
close to 1, and it is considerably lower only for the simulated tumor with volume
≈ 0.3 cm3.
These latter considerations are particularly interesting for early detection. In
fact, even if highly sensible technologies for the analysis of blood samples are
available, they will not be able to detect reliably more than a few ctDNA frag-
ments in a liquid biopsy. In Figure 4.3 we thus show the probabilities of at least
one, two and three ctDNA fragments present in a 7.5 ml plasma sample, again
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Figure 4.3: Detection probability of ctDNA fragments in a 15 ml liquid
biopsy for a given tumor depends on many parameters. Full lines denote the
probability to find at least 1 (blue), 2 (orange), or 3 (red) mutant ctDNA fragments in
a liquid biopsy of 15 ml blood (≈ 7.5 ml plasma).
The plots depicted in Figure 4.3A confirm that tumors with fewer than 109
cells rarely shed a detectable amount of ctDNA fragments. We then observe
that, at a given tumor size, higher ctDNA half-life time corresponds to a lower
elimination rate from the bloodstream and thus increases the number of mutant
ctDNA fragments (Figure 4.3B). Similarly, the ctDNA detection probabilities
quickly increase with the shedding probability at cell death (Figure 4.3D). On
the other hand, Figure 4.3C confirms that slowly growing tumors likely yield a
higher number of ctDNA fragment in a plasma sample than fast growing ones.
4.4 General Framework
The results we have derived so far to describe ctDNA shedding by cancerous and
healthy cells can be extended in several ways. Firstly, so far we have focussed on
the case where biomarker shedding happens only at cell apoptosis, but our model
72
can be generalized to include shedding also at cell necrosis (per unity of time)
and proliferation. Furthermore, we presented size distributions in the asymptotic
limit of large primary tumor sizes - small shedding rates, and similar distribu-
tions can be obtained also in the asymptotic limit for large times - small shedding
rates. Finally, even taking into account multiple shedding dynamics it is possible
to compute exact probability distributions for the processes At, Bt and Ct at
any given time t. In the following we will discuss in greater details these three
generalizations.
In order to include in our model the possibility of biomarker shedding by
cancerous cells also at necrosis and proliferations, we consider the following set
of transitions for the process (At, Ct)
A −→ AAC rate αA µα , rate ν2 ,
A −→ AA rate αA (1− µα) , rate αA − ν2 ,
A −→ AC rate ν1 , rate ν1 ,
A −→ C rate βA µβ , rate ν0 ,
A −→ ∅ rate βA (1− µβ) , rate βA − ν0 ,
C −→ ∅ rate ε , rate ε .
(4.7)
Here, µβ and µα represent the shedding probabilities at apoptosis and prolifera-
tion, respectively. Similarly, ν0 = βA µβ, ν1 and ν2 = αA µα denote the shedding
rates at cancerous cells apoptosis, necrosis and reproduction. The total shedding
rate is then defined by νA = ν0 + ν1 + ν2.
4.4.1 Asymptotic results with multiple shedding dynamics
With the updated definition of the total shedding rate νA, we still have that
biomarker molecules are shed by cancer cells as a Cox process with intensity
(νAAt)t≥0. Hence, the derivation of C
A
TM
distribution follows exactly as before. In
particular, we find again that for a large primary tumor size M and a small total
shedding rate νA, the number of biomarker molecules present in the bloodstream




Asymptotic results for large times
A similar derivation provides CAt size distribution in the asymptotic limit for
large time and small total shedding rate. Following again the results presented
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in [37], we see that under this limit and conditioning on At survival the total
number of biomarker molecules shed up to time t converges in finite dimensional
distributions to a Poisson random variable with mean WAνAe
λAt
λA
, where WA is
the same as in equation (4.1). In particular, we recall that, conditioned on At





distribution (see equation (1.13)). The
number of shed biomarker molecules still present in the bloodstream at time t is

















Here r(z) denotes the probability generating function of the process initiated by
a randomly selected molecule, but as the biomarker cannot reproduce this is a
pure death branching process whose size can only be 1 or 0. The probability
generating function of such a process is r(z) = ε+λAz
ε+λA
(see equation (1.4)). Using















Notice that the same steps can be repeated to derive more formally our asymptotic
results for large primary tumor sizes. We recognize the last expression as the
probability generating function of a geometric random variable, and so for large




αAνAeλAt + λA(ε+ λA)
)
. (4.8)







The asymptotic results previously derived provide a relatively simple toolbox to
quantify the correlation between ctDNA levels and tumor burden. In principle,
however, our mathematical framework can be used for other biomarkers - or
entirely different applications - where the model parameters do not fall in the
asymptotic regimes considered so far. For this reason we now show how to derive
the exact distributions of the processes At, Bt and Ct, for any given time t and
combinations of shedding rates.
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Probability generating functions
In order to compute the exact distribution of At, Bt and Ct we first derive the
joint probability generating functions of the processes (At, C
A
t ) and (Bt, C
B
t ).
The marginal generating functions then follow straightforwardly, and provide the
probability distributions of the single processes by simple analytical or numerical
inversion.
In order to simplify the notation, where no ambiguity is caused we will here-
after omit the subscripts A and B for the model parameters.
Process (At, C
A
t ). Our derivation for the process (At, C
A
t ) is adapted from that
in [13, 14], which first obtained similar results for a two-type branching process
where the second type has the ability to reproduce but shedding (or mutations)
can happen only at wild-type cell death. As before, the process is completely
defined by the set of transitions (4.7). For any given initial condition let us denote
P ∗m,n(t) = P ((At, C
A
t ) = (m,n) | (A0, CA0 ) = ∗). The corresponding probability
generating function is then defined as





















= ε δm,0δn,0 − εP (0,1)m,n .
(4.9)
Multiplying both sides of equation (4.9) by xmyn and summing over all non-
negative m,n we find
∂tP




(2,1) − (α + β + ν1)P(1,0) ,
∂tP
(0,1) = ε− εP(0,1) .
Next, we notice that






because of the independence of the progenies of the two initial cells. By applying
this property and introducing the notation
A(x, y, t) = P(1,0)(x, y, t), C(x, y, t) = P(0,1)(x, y, t) ,
we reduce to the following system of first order differential equations
∂tA = (α− ν2)A2 + (β − ν0) + ν0C + ν1AC + ν2A2C − (α + β + ν1)A,
(4.10)
∂tC = ε− εC , (4.11)
with initial conditions
A(x, y, 0) = x , (4.12)
C(x, y, 0) = y . (4.13)
Equation (4.11), subject to the initial condition (4.13), has solution
C(x, y, t) = 1 + (y − 1)e−εt . (4.14)
Plugging this back into equation (4.10) we get
∂tA =
[








β + ν0(y − 1)e−εt
]
.
We first apply the change of variables s = e−εt and find
∂sA = −
[α + ν2(y − 1)s]
εs
A2 − [ν1(y − 1)s− α− β]
εs
A − [β + ν0(y − 1)s]
εs
.

























, b1 = −
ν1(y − 1)
ε





Notice that we are interested in the probability generating function A(x, y, t) for
t ≥ 0, that corresponds to 0 < s ≤ 1. Equation (4.15) is a Riccati equation,
which can be reduced to a second order ODE. In order to do so, we define
X(x, y, s) =
a2 + b2s
s




(a2 + b2s)(a1 + b1s)− a2
s(a2 + b2s)
X +















so that equation (4.16) transforms into
∂2s Y −
(a2 + b2s)(a1 + b1s)− a2
s(a2 + b2s)
∂sY +
(a2 + b2s)(a0 + b0s)
s2
Y = 0 . (4.17)
Equation (4.17) is a second order linear differential equation with rational coeffi-
cients. It has three singular points - s = 0 and s = −a2
b2
being regular and s =∞
being irregular with rank 1. Hence, equation (4.17) is a single confluent Heun
equation [164]. To bring it into standard form we first move the non-zero regular
singularity to 1 through the change of variable z = − b2
a2


















Y = 0 . (4.18)
We now look for a solution to equation (4.18) of the form
Y (z) = zmenzf(z) , (4.19)
which implies
∂zY = z






f + 2z(m+ nz)f ′ + z2f ′′
}
.
Substituting these expressions into equation (4.18) and rearranging, we reduce to







f = 0 , (4.20)
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where P (z) and Q(z) are two polynomials of second and third degree in z, re-
spectively. However, it is easily checked that by taking









the first and last coefficients of the polynomial Q(z) become zero. Hence, for













f = 0 . (4.22)
Here, the parameters γ, δ and η follow from the decomposition in partial fractions
of P (z)
z(z−1) while ω and ρ correspond to the coefficients of second and first degree
terms in Q(z), respectively - when m and n are set as in equation (4.21). Explicit

























(α + β)ν1 − (α− β)
√







(α + β − ε)ν1 − (α− β + ε)
√
ν21 − 4ν0ν2 + 2[αν0 + (β − ε)ν2]
}
.
Now, equation (4.22) is the standard form of the single confluent Heun equation.
Solutions to such a second order differential equation are called confluent Heun
functions and depend on six arguments - the five parameters of the equation and
the independent variable z. A standardized package for numerical and symboli-
cal computations involving Heun functions is currently provided only by Maple
[136], which includes in particular the procedures HeunC and HeunCPrime for the
evaluation of confluent Heun functions and their z derivative, respectively. Con-
sistently with these implementations the general solution of equation (4.22) can
be written as
























are the confluent Heun functions uniquely determined by the following initial
conditions






h2(0) = 1, h
′
2(0) =




Here h′i denotes the z derivative of the confluent Heun functions hi. As mentioned
before these are implemented by the Maple procedure HeunCPrime and uniquely
determined by an additional condition on h′′i (0), too cumbersome to be reported
here. Also notice that the expression in equation (4.24) contains only one in-
tegrating constant, D, as our derivation spawns from a first order differential
equation. By plugging such expression back into equation (4.19), the solution to
equation (4.18) becomes
Y (z) = zmenzf(z) = zmenzh1(z) +Dz
1+m−γenzh2(z) .
Next, we denote the derivative of f(z) as
g(z) = f ′(z) = h′1(z) +Dz
−γ[(1− γ)h2(z) + zh′2(z)] . (4.26)
Hence, recalling that z = − b2
a2
s = ks and that X(x, y, s) = −∂sY
Y
, we find
X(x, y, s) = −(m+ nks)f(ks) + ksg(ks)
sf(ks)
. (4.27)
Notice that in terms of the original parameters of our model the coefficient k is
given by k = µα(y − 1) and thus depends on y. We can now apply the initial
condition for X(x, y, s) to find the value of the constant D. Since s = e−εt and
X(x, y, s) = a2+b2s
s
A(x, y, s), the initial condition A(x, y, t = 0) = x translates
to X(x, y, s = 1) = (a2 + b2)x = a2(1 − k)x. Therefore equation (4.27) at s = 1
implies
a2(1− k)x = −




Substituting the expressions for f and its derivative (equations (4.24) and (4.26),
respectively) and solving for D we find
D = − (m+ nk + a2x− ka2x)h1(k) + kh
′
1(k)
k1−γ[(m+ nk + a2x− ka2x+ 1− γ)h2(k) + kh′2(k)]
.
Hence, plugging this value back into equation (4.27) we find an expression for X
in terms of the functions hi(s) and h
′
i(s). Multiplying such expression by
s
a2(1−ks)
and substituting s = e−εt we eventually find
A(x, y, t) =
eλtK1(x, y)φ2(y, t)−K2(x, y)φ1(y, t)















































ψ1(y, t) = (1− ke−εt)h1(ke−εt) ,
ψ2(y, t) = (1− ke−εt)h2(ke−εt) .
(4.29)
This is the joint probability generating function of the processes At and C
A
t ,
starting from one A cell at time t = 0.




P(At = m | (A0, CA0 ) = (1, 0))xm ,
we take the limit for y → 1 in equation (4.28). By applying the conditions in
equation (4.25), we retrieve the probability generating function of a supercritical
birth-death process with net growth rate λ = α−β > 0 and extinction probability




P(CAt = n | (A0, CA0 ) = (1, 0))yn
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Figure 4.4: Comparison between simulated ctDNA levels and their exact
theoretical distributions with multiple shedding dynamics. Panels (A-G) show
the level of biomarker shed by cancer cells and still circulating in the bloodstream at
time t for all the possible combinations of non-zero shedding rates. Bars illustrate the
distribution of the number of biomarker molecules based on 104 simulations. Full red
lines illustrate the exact probability distribution at time t derived from equations (4.30),
(C.3) and (C.6) and perfectly agree with simulation results. Panel (H) similarly shows
the probability distribution of the primary tumor size. Parameter values: birth rate
αA = 0.051 per cell per day and death rate βA = 0.041 per cell per day; elimination
rate ε = 3.1× 10−5 per biomarker molecule per day; biomarker shedding probability per
cell death µβ = 10
−4, per cell reproduction µα = 1.5× 10−4, and shedding rate per day
(during cell necrosis) ν1 = 5× 10−5 per cell per day. All results are computed at time
t = 365 days from the primary tumor onset.
is derived by taking the limit for x → 1 in equation (4.28). The expression for
CA does not simplify significantly and becomes
CA(y, t) =
eλtK̄1(y)φ2(y, t)− K̄2(y)φ1(y, t)



















and the functions φ1, φ2, ψ1, ψ2 are defined as in equation (4.29). The function
CA(y, t) can be then inverted numerically (see Section 1.2.1) to find the distribu-
tion of the process CAt .
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When one or more of the shedding rates ν0, ν1 and ν2 are zero, the results
derived above assume slightly different forms. For a discussion of these special
cases and the corresponding probability generating functions, see Appendix C.2.1.
The probability mass function of CAt in the general case presented here and in
the special cases just mentioned is visualized by Figure 4.4.
Process (Bt, C
B
t ). We now derive exact results for the size distributions of the
processes Bt and C
B
t . So far we have assumed a constant population of healthy
cells and studied the asymptotic behaviour of the number of biomarker molecules
they shed. Here we first present additional details about this case, providing
the exact generating function of CBt at a given time t. Later, we show how a
derivation similar to that employed for the process (At, C
A
t ) can be used when Bt
is modelled by a critical branching birth-death process.
Constant growth. In the derivation of asymptotic results for our model we
already mentioned that if Bt is constant then C
B
t is a branching pure death
process with immigration and its exact probability generating function is given by
equation (4.3). In our setup we also assume that CBt is originally at equilibrium,
i.e. that it starts at the expected value of its large time asymptotic distribution.
Since we already saw that in this limit CBt converges to a Poisson random variable
with mean νB
ε

















Numerical inversion of this function then provides the exact distribution of the
process CBt at any given time t.
Critical growth. In our model Bt denotes the number of healthy or pre-
malignant cells extant at time t and with the ability to shed biomarker molecules
in the bloodstream. So far we have assumed that such a number stays constant
over time, but in principle we could expect it to fluctuate around a constant aver-
age value. For this reason, Bt can be modelled as a critical branching birth-death
process, i.e. as a process defined like At but with the same birth and death rates
αB = βB. Under this assumption, and assuming that the shedding probabilities
at cell apoptosis and proliferation are the same for cancerous and healthy cells,
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the set of transitions characterizing the two-type process (Bt, C
B
t ) are
B −→ BBC rate αB µα , rate ν ′2 ,
B −→ BB rate αB (1− µα) , rate αB − ν ′2 ,
B −→ BC rate ν ′1 , rate ν ′1 ,
B −→ C rate αB µβ , rate ν ′0 ,
B −→ ∅ rate αB (1− µβ) , rate αB − ν ′0 ,
C −→ ∅ rate ε , rate ε .
The exact probability generating functions for this process can be computed
through a derivation similar to that shown for (At, C
A
t ). Briefly, let us just rede-
fine P∗ as


















B(x, y, t) = P(1,0)(x, y, t), C′(x, y, t) = P(0,1)(x, y, t) .
As biomarker molecules are eliminated by the bloodstream at the same rate re-
gardless of the cell type that shed them, we have C′(x, y, t) = C(x, y, t), where
C(x, y, t) is given by equation (4.14). However, the function B(x, y, t) does not
follow straightforwardly from A(x, y, t) by simply substituting the rates for Bt
and taking the limit as βB → αB. The reason is that in this limit the two linearly
independent solutions h1(z) and h2(z) of the reduced equation become the same
and so one needs to write a general solution to the equation for f(z) in terms
of different functions. Adjusting this detail though, the subsequent steps can be
repeated and allow to derive an explicit expression for B(x, y, t). Then, the exact
probability generating function for the process (Bt, C
B
t ) is equal to
P(B0,C
B
0 )(x, y, t) = B(x, y, t)B0C(x, y, t)C
B
0 .
The marginal generating functions for the two single processes follow from the
y → 1 and x→ 1 limits, respectively. In particular, for any combination of non-
zero shedding rates the former coincides with the probability generating function
of a critical branching birth-death process with rate βB and B0 initial individuals,
as given by equation (1.4). The marginal generating function of CBt can instead
be inverted numerically to derive the exact probability distribution of the process.
However, while the computations just described are feasible, modelling Bt as a
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critical branching birth-death process lead to tedious complications and does not
practically change the dynamics of the model. These complications are related to
the fact that a critical branching process eventually gets extinct with probability
one (see Section 1.2.1). Hence, while we are interested in the large time limit
distribution of Bt, under these modelling assumptions such a limit converges to
a point mass at zero and it is not possible to condition on Bt eventual survival
either. On the other hand, since Bt starts with a very large number of cells the
time required by Bt to become extinct would be unrealistically long. Indeed, the
expected time to extinction for a critical branching process is infinite, and using
equation (1.7) we see that if Bt starts with 3 × 108 cells (see Section 4.2.1) the
probability it gets extinct in a million years is still around 10−4. For the same
principle, the probability that Bt exhibits significant deviations from B0 within
human lifetime is small. To quantify the probability of such fluctuations we can
exploit the Chebyshev inequality; using again βB = 0.1 and B0 = 3 × 108 this
yields P(|B100y − 3× 108| ≥ 1.5× 107) < 0.01, which says that even waiting 100
years the probability of observing a deviation of at least 2% from the original
population size would still be lower than 1%.
Process Ct. Given the independence of biomarker shedding from cancerous and






C(y, t) = CA(y, t)CB(y, t) ,
where the two functions on the right hand side are given by equation (4.30) (see
also equations (C.3) and (C.6) for special cases) and equation (4.3) (assuming Bt
is constant), respectively. Once again, C(y, t) can be numerically inverted to find
the exact distribution of the process Ct.
The probability distributions derived in this section for the processes At, Bt
and Ct can also be conditioned on At eventual survival, or on the size of one of
these processes. The form of these distributions, together with expressions for the
expected value of the processes and additional information on the implementation
of the sampling scheme, are presented in Appendix C.2.
4.5 Discussion
Liquid biopsies combined with deep sequencing of circulating tumor DNA offer
new opportunities for cancer early detection and treatment monitoring. How-
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ever, whether or not such an approach can also detect small and yet asymp-
tomatic tumors with sufficiently high sensitivity and specificity has not yet been
demonstrated. To explore the fundamental biological and mechanistic limita-
tions of ctDNA-based detection tests, we developed a fully stochastic model of
tumor growth and ctDNA shedding. In this model, ctDNA fragments are released
stochastically by both healthy and cancerous cells and evolve as branching pure
death processes. We further assumed that the population of healthy cells remain
constant over time, and described the primary tumor growth as a supercritical
branching birth-death process. In this framework, we showed that the number of
ctDNA fragments present in the bloodstream - or in a blood sample - when the
primary tumor is made of a large number of cells follows a Poisson distribution.
By applying this model to an early stage lung cancer cohort, we inferred a
mean shedding rate of 1.2 × 10−5 ctDNA whole genome equivalents per cancer
cell per day. For tumors with 1 billion cells (≈ 1 cm3), we calculate that a 15
ml liquid biopsy contains at least two whole genome equivalents of ctDNA with
a probability of ≈ 45%. Assuming a tumor exhibits three somatic driver point
mutations, we expect to find at least two mutant ctDNA fragments for 84% of the
patients. In contrast, less than 17% of tumors of size 0.25 cm3 produce at least
two mutant ctDNA fragments per liquid biopsy. An equally sized benign lesion
with two driver mutations would be detected with a probability of only 2.2% due
to a smaller fraction of cells undergoing apoptosis per unit of time. The same
argument explains why fast growing tumors can produce lower levels of ctDNA
than slower growing tumors.
While further studies are needed to assess the viability of liquid biopsies and
circulating tumor DNA for early cancer detection, our model provides a quanti-
tative framework to explore their potential and limitations. This framework can
be applied to different cancer types or extended to more complicated scenarios.
For example, it can be used to correlate the tumor burden with the results of
repeated biopsies, or with the analysis of blood tests based on a panel of multiple




In the introduction of this thesis we highlighted the key role of many mathemati-
cal models in the study of cancer evolutionary dynamics. These models are based
on different mathematical tools and have collectively been employed to investi-
gate a wide range of biological processes related to the development of a tumor.
In particular, the theoretical framework designed by Luria and Delbrück, and its
generalization by Lea and Coulson, provide a fitting mathematical description
for scenarios where a growing tumor seeds a second population. Inspired by this
approach, we employed a similar setting to explore biological aspects underlying
metastasis formation and the shedding of cancer biomarkers.
Our models make extensive use of the theory of branching and birth-death
processes. In the first two chapters of this thesis we thus presented the main no-
tions in these fields, that we subsequently exploit for the analysis of our models.
After discussing preliminary mathematical results, in Chapter 2 we focussed on
the probability distributions of first passage times in branching birth-death pro-
cesses. These random variables can describe how long a cellular population takes
to reach a given size, and are thus extremely useful for the study of cancer growth.
We presented expressions for the distributions and first moments of hitting times
to a finite size, for both noncritical and critical processes. We then investigated
the asymptotic limit of these hitting times to large sizes. Such results are partic-
ularly relevant for our models, as tumors typically start to show symptoms and
become detectable only when made of a large number of cells. The asymptotic
distributions of hitting times in noncritical branching birth-death processes are
of an extreme value (Gumbel) type. The reason why these times asymptotically
behave like the maximum of i.i.d. random variables is not obvious, and we thus
presented a mathematical argument to interpret this result.
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In Chapter 3 we then discussed our model of cancer recurrence. In this set-
ting we describe the growth of a primary tumor as a deterministic function and
assume it seeds metastases at a rate proportional to its size. These secondary
lesions are thus initiated as a non-homogeneous Poisson process. Once they are
generated, each of them evolves as a supercritical branching birth-death process
conditioned on non-extinction. The asymptotic results discussed in the previous
chapter allow us to characterize the time taken by each of these metastases to
reach a large detectable size. The smallest of these times is then defined as the
time to cancer recurrence. In the special case where the primary tumor growth is
modelled by an exponential function, we showed that this time follows a Gumbel
distribution for the minimum of i.i.d. random variables.
Next, we extended the previous framework to include a scenario where the
primary tumor is surgically removed at a given time, modelled by a cut-off time
for the primary tumor growth function. By embedding this event, we categorize
all metastases into those that become detectable before (synchronous) or after
(metachronous) the primary tumor resection. Under these modelling assumptions
we derived the probability of several clinically relevant events, in particular that
of established but all undetectable metastases, and discussed how the distribution
of the relapse time changes when conditioned on these events.
After this qualitative analysis, we tested our model with parameter estimates
collected for five different cancer types. The predicted time to cancer recurrence
and fraction of patients with synchronous metastases fall in the ranges reported
in clinical literature, suggesting that our simple setup is able to capture the main
dynamics governing cancer relapse and to provide meaningful information about
the time to recurrence.
Finally, in Chapter 4 we introduced a model for cancer biomarker shedding,
focussing on circulating tumor DNA. This model can be applied to study liquid
biopsies - recently developed screening techniques based on blood tests - to deter-
mine their potential to detect cancer early. In this case, we describe the growth of
a primary tumor as a supercritical branching birth-death process conditioned on
non-extinction. When a cancerous cell dies, it has a given probability of releasing
a ctDNA fragment into the circulation. We therefore assumed that the tumor
sheds ctDNA at a rate proportional to its size, and that this shedding only hap-
pens at cell apoptosis. Under these hypotheses, ctDNA fragments are thus shed
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as a Cox process. Since they cannot reproduce and are eliminated by the blood-
stream at a fixed rate, we model their evolution as a branching pure death process.
By applying to this setting parameter estimates inferred for lung cancer, we
were able to quantify the correlation between tumor burden and ctDNA levels in
a plasma sample. We then extended our mathematical framework to allow for
biomarker shedding not only at cell apoptosis but also at necrosis or prolifera-
tion. Furthermore, while our main results for ctDNA shedding were expressed in
their asymptotic forms for large primary tumor size, we derived the probability
distribution of biomarker levels at a given time. This model can thus be applied
to a wide range of contexts and represents a general mathematical tool to better
correlate features of physiological or pathological conditions with the levels of
related biomarkers in the blood.
As a whole, the work presented in this thesis stems from non-trivial theoretical
results and provides insight into both quantitative and qualitative features of
cancer evolution, hence fitting into the context of mathematical contributions to
the study of biological processes.
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Appendix A
Appendix to Chapter 2
In this appendix we show supplementary material for our discussion of hitting
times distributions in branching birth-death processes.
A.1 Hitting times with arbitrary initial condition
Proposition 2.3.2 exploits the result in Theorem 2.3.1 to derive the probability
distribution of the hitting time to M in a birth-death process with reflecting
boundary at 0 and starting with 1 < n0 < M individuals. Here, we provide a
proof based on the Laplace transforms of P0(TM ≤ t) and P0(Tn0 ≤ t).
Proof of Proposition 2.3.2. Given the definitions of λi and µj, Theorem 2.3.1 tells
us that



















P(Tj ≤ t | Z0 = i)
the probability density of the first passage time to j starting with i individuals.
Then, from equation (A.1) we find
f0,n0(t) = µ1e
−µ1t ∗ · · · ∗ µn0e−µn0 t ,
f0,M(t) = λ1e
−λ1t ∗ · · · ∗ λMe−λM t ,
(A.2)
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where the asterisk sign denotes the convolution operation. Additionally, we define





as the Laplace transform of the density fi,j(t). By recalling the following proper-
ties of Laplace transforms,


















On the other hand we also see that f0,M(t) = f0,n0(t) ∗ fn0,M(t), which in turn





λ1 · · ·λM











Consider now the rational function P (s)/R(s). Since all the eigenvalues λis are
distinct (see e.g. [105]) and we are assuming that n0 < M , there exists a unique
















Thus, to conclude the proof, we only need to show that the coefficients ξi have
exactly the form given in equation (2.5). To see this, for any fixed k, 1 ≤ k ≤M ,
















Then, by substituting s = −λk we immediately recover for every k the expression
given in equation (2.5).
A.2 First moments
In this section we discuss how to derive the mean and variance of TM conditional
on ΩM . We consider separately the cases of noncritical and critical branching
birth-death processes, and results for finite M and in the asymptotic limit for M
large.
A.2.1 Noncritical case
Let us formally define for every i ≥ 1 the i-th first upward passage time and the
i-th interevent time, respectively, as
τi = Ti+1 − Ti, Yi = min{Ti+1 − Ti, Ti−1 − Ti} .
The interevent times Yi of a branching birth-death process are exponentially
distributed with parameters (α + β)i. By denoting as usual Ẑn the embedded
chain, we can also define 1i,j as the indicator function for the event {Ẑ1 = j |
Ẑ0 = i}. The first upward passage times τi satisfy the following well known
recursive relation (see e.g. [105])
τi = Yi + 1i,i−1 · (τi−1 + τi) . (A.3)
Such a relation will be fundamental for the next proofs.
Finite results
Proof of Proposition 2.3.3. Recall that p̃i,j denote the one-step transition proba-
bilites of Zt conditioned on Ω
j. Taking conditional expectations on both sides of
equation (A.3) we first find







E[τi−1 | Ωi+1] =: aiE[Yi] + biE[τi−1 | Ωi+1] ,






. Notice that, for every i ≥ 1, the ran-
dom variables Yi does not depend on the event Ωi+1 and E[τ2 | Ωi+1] = E[Y1].
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Therefore, we can iterate the relation above to get















aj if j = i ,aj (∏ik=j+1 bk) if j < i .
Now, by plugging in this expression the definitions of ai and bi and the formulas
for the conditional probabilities given by equation (2.9), we find that
ξij =
qi(1 + q)(1− qj)2
qj(1− qi)(1− qi+1)
, for every j ≤ i . (A.5)
Furthermore, we observe that
E[TM | Z0 = n0,ΩM ] =
M−1∑
i=n0
E[τi | Ωi+1] . (A.6)
Hence, putting together equations (A.4) to (A.6) and recalling that the interevent
times satisfy Yi ∼ Exp(iα(1 + q)) for every i ≥ 1, we find






















Once these expectations are known, they can in turn be used to obtain the con-
ditional variance of TM . The corresponding proof follows closely the steps made
to derive the expectation formula, but require heavier computations, and we will
thus only provide a sketch of the demonstration.
Proposition A.2.1. Let Zt be a supercritical branching birth-death process with
birth rate α and death rate β. Then















qi(1 + q)(1− qj)2
qj(1− qi)(1− qi+1)
, ηij =
qi+1(1− qi−1)(1− qj)(1− qj+1)
qj(1 + q)(1− qi)2(1− qi+1)
,
and
cj = (E[τj−1 | Ωj] + E[τj | Ωj+1])2 .
Sketch of the proof. Let us define vi = Var(τi | Ωi+1). Then, by taking variance
on both sides of equation (A.3), we find
vi = aivi−1 + biVar(Yi) + p̃i,i−1ci ,
where ai and bi are defined exactly as in the proof of Proposition 2.3.3. Hence,








Here, the first sum follows again in the very same way as for equation (A.3), while
the second one comes from the additional term p̃i,i−1ci in the recursive relation
for vi. It is then easy to see that
ηij =





bk if j < i ,
which gives the desired expressions for ηij by just plugging in the definitions of
p̃j,j−1, bk and simplifying the product. The final result follows by summing over
i in the range [n0, N − 1].
Asymptotic results
The asymptotic limits of the quantities we just studied can instead be derived
moving from Proposition 2.4.2. Also in this case, we show how to compute the
expression for the mean, and then discuss how a similar derivation can be used
to obtain the variance of TM .
Proof of Proposition 2.4.3. Equation (2.16) tells us that the hitting time TM ,
conditioned on non-extinction and n0 initial individuals, is distributed like a
mixture of n0 generalized Gumbel random variables with weights cj. If we denote














kfj(t)dt the k-th moment of each general-
ized Gumbel random variable, we see that






When k = 1, the relation above provides immediately the expression in the
statement for E[TM ≤ t | Z0 = n0,ΩM ], by simply substituting the parameters of
the generalized Gumbel distributions in equation (2.16) and recalling the formulas
for their means, given by equation (1.18).
Using the notation introduced in the previous proof, the variance of TM can then
be written as





j − (E[TM ≤ t | Z0 = n0,ΩM ])
2
and similarly follows by the two results referenced above.
A.2.2 Critical case
We now derive the expression for the mean of TM conditional on Ω
M in the critical
case reported in Proposition 2.3.5.
Proof of Proposition 2.3.5. Let us first define Si(x) :=
∑i−1
k=0 x
k. Then, we have
that for every i ≥ 1, 1−qi = (1−q)Si(q) and hence we can rewrite equation (2.12)
as












Then, since Si(1) = i for every i, the statement follows by simply substituting
q = 1 in the expression above.
The corresponding variance of TM can be similarly obtained from equation (A.7).
However, such a derivation involves long and tedious computations that we do





















−1 denotes the k-th harmonic number.
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The asymptotic limits of this mean and variance as M gets large follow straight-
forwardly from their finite expressions, and are shown in equation (2.17).
A.3 Asymptotic distributions
In this section we present the steps necessary to derive the asymptotic distribution
of the first passage time to M , as M gets large, conditioned on ΩM and n0 ≥ 1
initial individuals.
A.3.1 Noncritical case
Theorem 2.4.1 provides the asymptotic distribution of the first passage time to
a large size M for a supercritical branching birth-death process conditioned on
ΩM and one initial individual. The proof we presented for such theorem relies
on a martingale argument, that can be extended to derive a similar result for
processes starting with n0 > 1 individuals. To this purpose, we first show a few
auxiliary results.
Let Zt be a supercritical branching birth-death process with birth rate α, death
rate β and starting with n0 ≥ 1 individuals. Moreover, denote λ = α − β > 0
its net growth rate and Ω∞ = {Zt > 0 for all t} its eventual survival event, for
which we recall that P(Ω∞ | Z0 = 1) = 1− β/α = 1− q < 1 (see equation (1.8)).
Following the steps shown in Section 1.2.1, we see that Zt divided by its mean,
E[Zt] = n0eλt, is a non-negative martingale. Such a process thus converges to a
limit non-negative random variable W(n0). Repeating now the argument used in

















where Y(n0) := n0W(n0). The probability distribution of the limit random variable
Y(n0) conditioned on non-extinction is provided by the following.
Proposition A.3.1. Let Y(n0) be defined as above. Then its cumulative distribu-
tion function conditioned on Ω∞ is equal to




















for every j = 0, . . . , n0 − 1.









t are the independent processes generated by the initial n0 individuals.
In particular, each Z
(i)
t is an i.i.d. copy of a supercritical branching birth-death
process with birth rate α, death rate β and starting with one individual. Hence,













(1) are n0 i.i.d. copies of the limit random variables W defined by equa-

























If we know how many of the initial processes survive, we can then use the explicit
distribution of Y
(i)














where 1 denotes the indicator function of an event. Intuitively, B represents the
number of the initial processes Z
(i)
t which will eventually die out. As we know
that these processes independently get extinct with the same probability q, we
have that B ∼ Bin(n0, q). By averaging over B, we then find
P(Y(n0) ≤ t) =
n0∑
j=0
P(B = j)P(Y(n0) ≤ t | B = j) . (A.11)




out, equation (A.11) can be further expanded as
P (Y(n0) ≤ t) = qn0 +
n0−1∑
j=0
P(B = j)P(Y(n0) ≤ t|B = j) . (A.12)
At the same time, since Ω0 and Ω∞ constitute a partition of the sample space we
also have
P(Y(n0) ≤ t) = P(Y(n0) ≤ t | Ω0) · P(Ω0) + P(Y(n0) ≤ t | Ω∞) · P(Ω∞)
= qn0 + (1− qn0)P(Y(n0) ≤ t | Ω∞) .
(A.13)
Therefore, by combining equations (A.12) and (A.13) we immediately find





P(B = j)P(Y(n0) ≤ t | B = j) . (A.14)
Now, the term P(Y(n0) ≤ t|B = j) is the distribution of the limit random variable
Y(n0) when n0 − j of the initial processes survive. By combining equations (1.12)
and (A.10), we thus find that this distribution coincides with that of a sum of
n0 − j i.i.d. exponential random variables with parameter 1− q. Equivalently, it
is an Erlang distribution with parameters n0 − j and 1− q, and is thus given by
(see e.g. [59])









The statement of the proposition then follows by plugging back into the expression
above and that for the binomial mass function of B.
Equation (A.9) can now be used to prove Proposition 2.4.2 and derive a for-
mula for the asymptotic limit of TM distribution conditioned on n0 ≥ 1 initial
individuals.
Proof of Proposition 2.4.2. The cumulative distribution function of the k-th gen-
eralized Gumbel distribution is given by equation (1.17). By substituting such
expression in equation (2.16), we see that the statement of the proposition is
equivalent to
















asymptotically for large M . Now, following the same steps we used for the proof
of Theorem 2.4.1, for large M we find
P(TM ≤ t | Z0 = n0,Ω∞) = P(Me−λTM ≥Me−λt | Z0 = n0,Ω∞)
∼ 1− P(Y(n0) ≤Me−λt | Ω∞) .
The last expression can then be expanded using equation (A.9) and provides
exactly equation (A.15).
A.3.2 Critical case
As M gets large, the asymptotic distribution of TM for a critical branching birth-
death process conditioned on non-extinction is determined by the corresponding
limit of the zeros of the associated Laguerre polynomials L
(1)
M (x). Here we thus
present classical results about the asymptotics of these zeros, and then show how
to use them to prove Theorem 2.4.4.
Proposition A.3.2. Let λM,i be the M zeros of the associated Laguerre polyno-
mial of order 1, L
(1)
M (x), in increasing order. Denote ji the positive zeros of the
Bessel function of the first kind, J1(x), also in increasing order. Then we have
lim
M→∞
(4M + 4)λM,i = j
2
i .
For a proof of this result, see for instance [73] and the references therein. The
asymptotic distribution of TM can then be obtained as follows.
Proof of Theorem 2.4.4. Proposition A.3.2 implies that as M gets large, the ze-
ros of L
(1)
M (x) satisfy λM,i ∼
j2i
4M + 4




. The statement thus follows by combining this asymptotic result
with Proposition 2.3.4.
A.4 Extreme value interpretation
In this section we provide auxiliary proofs to show the symmetry between the
asymptotic conditional first passage times distributions of a branching supercrit-
ical birth-death process Zt and the reversed process Z
∗
t .
Proof of Lemma 2.4.7. Since the last exit time R∗M is a non-negative random
variable, to show that it converges to zero in distribution it is sufficient to show
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that its expectation tends to zero, thanks to Markov’s inequality. First define
K∗M = # of Z
∗
t visits to M ,
Θ∗M = inf{t > 0 : Z∗t = M,Z∗s 6= M for some 0 < s < t} ,
and let us denote E∗M = E[ · | Z∗0 = M ]. Then, we can write






and from Wald’s equality this implies
E∗M [R∗M | Ω∗M ] = E∗M [K∗M − 1 | Ω∗M ]E∗M [Θ∗M | Ω∗M ] . (A.16)
Now, since Z∗t is a subcritical birth-death process, it will get extinct with proba-
bility one and hence all the states except 0 are transient. It follows in particular
that almost surely
1 ≤ E∗M [K∗M − 1 | Ω∗M ] <∞ . (A.17)
To prove our result we then need to show that E∗M [Θ∗M | Ω∗M ] goes to zero.
Consider the embedded chain Ẑ∗n and define
σ∗M = inf{n > 0 : Ẑ∗n = M} .
If Z∗t starts at with M individuals, σ
∗
M represents the number of transitions
that the process goes through before it gets back to size M for the first time.
Furthermore, if the process does go back to M at a certain time before extinction,
this time will be distributed as the sum of σ∗M exponential inter-event times. Now,
we also define the following
A =
{
ω : Ẑ∗n(ω) >
M
2
for all 0 ≤ n ≤ σ∗M(ω)
}
.
When Zt starts at M , the above represents the event that Zt does not reach sizes
smaller than or equal to M/2 before it gets back to M for the first time. It is
then easy to check that















. Let us denote ni, where i = 1, . . . , σ
∗
M , all the states
that the process Z∗t goes through in its trajectory back to M . We can then write












By averaging the last expression over A and applying equation (A.18), we find
that E∗M [Θ∗M | Ω∗M ] is bounded above by
E∗M [σ∗M | Ω∗M ] ·
2
M(α + β)
· (1− e−cM) + E∗M [σ∗M | Ω∗M ] ·
1
1 · (α + β)
· e−cM .
Finally, as we observed for the number of visits K∗M , the fact that M is a transient
state implies that E∗M [σ∗M | Ω∗M ] <∞ as well and so the bound above yields
E∗M [Θ∗M | Ω∗M ]
M→∞−→ 0 . (A.19)
The statement then follows by joining together equations (A.16), (A.17) and (A.19)
and using Markov’s inequality.
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Appendix B
Appendix to Chapter 3
In this appendix we provide additional details about the mathematical features
of our model for cancer recurrence.
B.1 Scaled relapse time distribution
In Section 3.2 we derived the general expression for the relapse time distribution,
which can be written as
P(τ ≤ t) = 1− e−ν(1−q)
∫ t




by combining equations (3.2) to (3.4). Here we show how to scale the detectable
size M out of the previous expression, so to split the distribution into a deter-





and apply two changes of variables: first we use s→ t− s and transform it into∫ t
0
n(t− s)e−(1−q)Me−λsds ,













































From the last two equations we also see that asymptotically as M →∞
E[τ ] ∼ 1
λ
logM + C, C = E[τ̄ ] . (B.1)
B.2 Explicit results for exponential primary growth
Two commonly employed growth functions for primary tumors are the exponen-
tial ne(t) = e
δt and the logistic nl(t) =
Keδt
K+eδt−1 ones (see e.g. [156]). A logistic
growth implies that the primary tumor has a carrying capacity K. During the
first stages of its development nl(t) follows the same exponential trajectory of
ne(t) and then approaches a constant growth as it gets closer to size K. As
the carrying capacity is typically large, this slowdown for nl(t) happens around
t̂ = log(K)/δ. The differences between the results provided by these two growths
functions thus depend on the probability of metastases being initiated by time t̂,
i.e. P(Kt̂ ≥ 1) ≈ 1− e−
ν(1−q)K
δ . Hence, if
ν(1− q)K
δ
 1 , (B.2)
metastases likely establish in the first stages of the primary growth, i.e. when
nl(t) ≈ ne(t). Otherwise, metastases are initiated late in the primary evolution,
when the two growth functions are substantially different. This feature is visual-
ized in Figure 3.1, where τ densities for a logistic growth are shown to converge
to the exponential ones as ν increases and the other parameters are fixed.
Using the parameter values from Table 3.2, however, we observe that the condition
in equation (B.2) is satisfied for all cancer types considered. In other words, our
estimates for ν, q,K and δ yield no difference between exponential and logistic
growth functions. In light of this, here we study in greater detail the results
obtained with ne(t).
Scaled relapse time. When n(t) = ne(t) = e
δt, the relapse time distribution
has an expression in terms of special functions. To show this, let us consider the
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distribution of the scaled relapse time τ as given by equation (3.5) and focus on
the integral ∫ t
−∞









































The scaled relapse time distribution for n(t) = eδt is thus given by





Γ( δλ ,(1−q)e−λt) . (B.3)
Since Γ(1, t) = e−t, for λ = δ this simplifies to






Small initiation limit. While the initiation rate can vary significantly across
different cancer types, ν is typically orders of magnitude smaller then all other
parameters. Hence, we now investigate τ distribution in the ν → 0 limit. Let us
first consider the result given by equation (B.3) for the scaled time to recurrence
τ and write it as





































Notice that the second exponential factor in equation (B.4) is bounded below by
1 and above by e
ν(1−q)
δ . Therefore, as ν → 0, the distribution of τ̄ asymptotically
converges to












Equivalently, for small initiation rates the scaled relapse time τ̄ asymptotically
















Mean relapse time. By combining the last result with equation (1.21) and
(B.1) we find that



















. Intuitively, the time to relapse is likely
to be determined by one of the first established metastases. Given the simple
dependence of E[τ ] on M and ν, we now compare it with the mean time to
detectability of the first metastasis, E[τ1]. Let us first recall that τ1 = σ1 + Θ1 is
equal to the sum of the first initiation time and the hitting time to M . As ν → 0,
the distribution of the first arrival σ1, given in general by 1− e−at , converges to a
























where C1 = − log(1−q)+γEδ . Moreover, the hitting times Θi follow the Gumbel




logM − C2 ,
for every i, where C2 = − log(1−q)+γEλ . Joining the last two results we get









+ C̃ , (B.5)
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where C̃ = C1 − C2. By comparing equation (B.5) with the expression for E[τ ],
we notice indeed the same M and ν dependence, but the constants C and C̃ have
different analytical forms.
Numerical computation. Finally, all the plots and computations reported
in this paper have been performed on Matlab R2018b. The lines of code below
provide an efficient way (in the example for the exponential case) to calculate the
relapse time distribution given by equation (3.4) for a vector of times tspan.
n = @(t)(exp(delta*t));
G = @(t)(exp(-(1-q)*M*exp(-lambda*t)));




Appendix to Chapter 4
In this appendix we show supplementary information for the model discussed in
Chapter 4. Following the structure used there, we first present material related
to the asymptotic distributions of the processes considered.
C.1 Asymptotic means and variances
Here we briefly summarize the expected values and variances of the processes
At and Ct in the asymptotic limits considered. These moments follow straight-
forwardly from the probability distributions derived in Chapter 4, and can be
later compared with their exact form. The process At is a supercritical branching
birth-death process with net growth rate λA, extinction probability qA and such
that A0 = 1. While at time TM = inf{At = M} the process At is clearly equal to
M , referring back to Section 1.2.1 we see that for large t
















where ΩA∞, denoting the event of At eventual survival, is such that P(ΩA∞) = 1−qA.
For the process CAt , given that (A0, C
A








































for a large primary tumor size and for a large time, respectively.
Next, while Bt is assumed constant, the process C
B
t exhibits the same large

































Joining these results together and applying the same initial conditions, for the




















for large M , and






















In this section we provide additional details about the exact distributions of the
processes At, Bt and Ct.
C.2.1 Special cases of multiple shedding dynamics
Here we present the special forms that the exact distributions derived in Sec-
tion 4.4.2 when one or more of the parameters µβ, ν1, µα are zero. In general,
among the nonzero shedding rates the one with the highest index determines the
special functions involved in the generating function A(x, y, t). As we showed
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these are confluent Heun functions when ν2 > 0, while we will see that they
become confluent hypergeometric functions when ν2 = 0 and ν1 > 0 and Bessel
functions of the first kind when ν2 = 0, ν1 = 0 and ν0 > 0. The remaining
cases follow by straightforward substitution from these three. Hence, we will
now provide a sketch of how the previous derivation can be adapted to the cases
ν2 = 0, ν1 > 0 and ν2 = 0, ν1 = 0, ν0 > 0. The steps up until equation (4.17) are
valid for all scenarios, so that will be the starting point of the adapted derivations.
Also notice that for all these cases the marginal probability generating function
A(y, t) remains unchanged, as the evolution of the process At is not affected by
its shedding activity.
Case µα = 0, ν1 > 0
When µα = 0 we have b2 = 0. Hence, equation (4.17) becomes
∂2s Y −





Y = 0 .
By seeking directly a solution of the form Y (s) = s−a2f(s) and then applying the
change of variables z = b1s, the equation above reduces to the standard form of
Kummer’s equation [3]
zf ′′(z) + (γ − z)f ′(z)− ωf(z) = 0 , (C.1)
where








Including again only one integrating constant D, its solution can be expressed in
terms of the confluent hypergeometric function 1F1 as
f(z) = 1F1(ω, γ, z) +Dz
1−γ
1F1(ω − γ + 1, 2− γ, z) .
Substituting back we immediately find an expression for the solution Y (s) in
terms of





1F1(a, b, z) =
a
b
1F1(a+ 1, b+ 1, z) ,
the derivative of Y (s) can be computed in terms of the functions h1, h2, g1 and
g2, where
g1(s) = 1F1(ω + 1, γ + 1, b1s), g2(s) = 1F1(ω − γ + 2, 3− γ, b1s) .
Joining these results together we find an expression for X(s), in terms of the same
functions. This expression still depends on the integrating constant D, which is
determined by the initial condition X(x, y, s = 1) = a2x. Then, multiplying
X(x, y, s) by s
a2
and substituting s = e−εt we eventually find
A(x, y, t) =
eλtK1(x, y)φ2(y, t)−K2(x, y)φ1(y, t)
eλtK1(x, y)ψ1(y, t)−K2(x, y)ψ2(y, t)
, (C.2)
where
K1(x, y) = (α− β + ε)(1− x)h1(y, 0)− (ν1 + ν0)(y − 1)g1(y, 0) ,
K2(x, y) = (α− β − ε)(β − αx)h2(y, 0) + (βν1 + αν0)(y − 1)g2(y, 0) ,
φ1(y, t) = (α− β + ε)h1(y, t)− (ν1 + ν0)(y − 1)e−εtg1(y, t) ,
φ2(y, t) = β(α− β − ε)h2(y, t) + (βν1 + αν0)(y − 1)e−εtg2(y, t) ,
ψ1(y, t) = (α− β + ε)h1(y, t) ,
ψ2(y, t) = α(α− β − ε)h2(y, t) .
The marginal probability generating function for the process CAt becomes
CA(y, t) =
eλtK̄1(y)φ2(y, t)− K̄2(y)φ1(y, t)
eλtK̄1(y)ψ1(y, t)− K̄2(y)ψ2(y, t)
, (C.3)
where
K̄1(y) = −(ν1 + ν0)(y − 1)g1(y, 0) ,
K̄2(y) = (α− β − ε)(β − α)h2(y, 0) + (βν1 + αν0)(y − 1)g2(y, 0) .
109
Case µα = 0, ν1 = 0







Y = 0 .




s and by seeking a solution
of the form Y (z) = za1f(z) we reduce to the Bessel equation [3]
z2f ′′ + zf ′ + [z2 − (a2 − a0)2]f = 0 . (C.4)
The solution to equation (C.4) is given by the sum of two Bessel functions of first
kind Jν(z)
f(z) = Ja2−a0(z) +DJa0−a2(z) .










we can also express the derivative of Y (s) through h1, h2, g1 and g2, where
g1(s) = Ja0−a2+1(c
√
s), g2(s) = Ja2−a0+1(c
√
s) .
By joining such expression we first derive X(s), and then find the integrating
constant D by applying the initial condition X(x, y, s = 1) = a2x. Once again,
we now multiply by s
a2
and substitute s = e−εt to find
A(x, y, t) =
K1(x, y)φ2(y, t)−K2(x, y)φ1(y, t)
K1(x, y)ψ2(y, t)−K2(x, y)ψ1(y, t)
, (C.5)
where
K1(x, y) = (αx− α)h1(y, 0) +
√
αν0(y − 1)g1(y, 0) ,
K2(x, y) = (αx− β)h2(y, 0) +
√
αν0(y − 1)g2(y, 0) ,












ψ1(y, t) = αh1(t) ,
ψ2(y, t) = αh2(t) .
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From here we can recover the usual marginal probability generating function for
the process At by considering the expansions of Bessel functions Jw(z) around
z = 0. The marginal probability generating function for the process CAt is instead
given by
CA(y, t) =
K̄1(y)φ2(y, t)− K̄2(y)φ1(y, t)





αν0(y − 1)g1(y, 0) ,
K̄2(y) = (α− β)h2(y, 0) +
√
αν0(y − 1)g2(y, 0) .
Finally, we remark that in all the derivations above, there are special cases of
the equation f(z) that require extra attention. Namely, if some of the equation
coefficients are integers, then its general solution assumes a slightly different
expression than the one reported. However, it is unlikely that real estimates lead
to such special cases, which therefore we do not discuss here.
C.2.2 Conditional distributions
In the summary of our model for biomarker shedding we pointed out that we
are interested in the probability distributions of the processes At, Bt and Ct con-
ditional on At non-extinction. Therefore, the asymptotic results derived in the
previous sections are conditioned on the event ΩA∞. Here we show how a similar
conditioning can be applied to the exact distributions.
Let us stress that all the probabilities involved in the following derivations are
associated with the usual initial conditions for the processes At, Bt and Ct. For
clarity we will not introduce a new notation for the corresponding conditioning,
and hereafter we will thus implicitly denote


















Conditioning on At survival
As we are dealing with exact distributions at a given time, here we need to
condition on the event of At survival up to time t, that is Ω
A
t = {At > 0}. Let
us denote qAt = 1 − P(ΩAt ) = P(At = 0). Such a probability is equal to A(0, t),
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At = m | ΩAt
)
=




ΩAt | At = m
)
,
for any m ≥ 0. The term P
(
ΩAt | At = m
)
, however, is equal to 0 for m = 0 and
to 1 for every m ≥ 1. Hence, we get
P
(
At = m | ΩAt
)
=
P (At = m)
1− qAt
,
for everym ≥ 1, and 0 otherwise. Similar steps allow to compute P
(
CAt = n | ΩAt
)
.
In this case we find
P
(


























Here, the terms P(CAt = n) follow from the probability generating function








can be obtained by
inverting the function A(0, y, t).
Conditioning on one process size
The distribution of the total number of biomarker molecules present in the blood-
stream at time t conditioned on the primary tumor size at that time is





























t = n− i
)
follow from inverting the joint
probability generating function A(x, y, t). Moreover in this case, if we consider a
strictly positive primary tumor sizem, conditioning onAt survival is not necessary
as {At = m} ⊂ Ωt. The exact probability mass function of CAt conditioned on
the primary tumor size and its comparison with the asymptotic results obtained
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Figure C.1: Comparison between simulated biomarker levels, their exact
and asymptotic theoretical distributions conditional on non-extinction of
the primary tumor, with multiple shedding dynamics. Panels (A-G) show the
level of biomarker shed by cancer cells and still circulating in the bloodstream at time t
for all the possible combinations of non-zero shedding rates. Bars illustrate the distri-
bution of the number of biomarker molecules based on 104 simulations. The probability
distributions illustrated are all conditional on primary tumor survival up to time t.
Full red lines illustrate the exact probability distribution at time t derived from equa-
tions (4.30), (C.3) and (C.6), while the yellow squares represent the asymptotic results
for large times and small shedding rate obtained from equation (4.8). Both perfectly
agree with simulation results. Panel (H) similarly shows the probability distribution of
the primary tumor size. Parameter values: birth rate b = 0.051 per cell per day and
death rate d = 0.041 per cell per day; elimination rate ε = 3.1 × 10−5 per biomarker
molecule per day; biomarker shedding probability per cell death qd = 10
−4, per cell re-
production qb = 1.5× 10−4, and shedding rate per day (at cell necrosis) λ1 = 5× 10−5
per cell per day. All results are computed at time t = 365 days from the primary tumor
onset.
from equation (4.8) are illustrated in Figure C.1.
Now, once the exact probability mass function of Ct is known one can conversely
condition on the total number of biomarker molecules present and ask how this
affects the primary tumor size distributions. To see this we can write
P(At = m | Ct = n) =












t = n− i
)∑n
i=0 P (CBt = i)P (CAt = n− i)
.
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By further conditioning on At survival up to t we get
P(At = m | Ct = n,ΩAt ) =
P(At = m,ΩAt | Ct = n)
P(ΩAt | Ct = n)
=
(1− qAt )P(At = m | Ct = n)
P(Ct = n | ΩAt )P(Ct = n)
.
Finally, let us recall that as (Bt, C
B
t ) is independent of the primary tumor growth





The expected value and variance of the processes At, Bt and Ct at any given
time t can immediately be computed by the corresponding generating functions
(see Section 1.2.1). In the following we summarize formulas for the expectations,
which are all implicitly conditional on (A0, C
A






cancerous cells population we have
E[At] = eλAt, Var(At) =
1 + qA
1− qA
eλAt(eλAt − 1) ,
and
E[At | ΩAt ] =
eλAt − qA
1− qA
, Var(At | ΩAt ) =
(1− qAe−λAt)(1 + 2qA)eλAt(eλAt − 1)
(1− qA)2
,
When the healthy population is modelled by a critical branching birth-death
process we find
E[Bt] ≡ B0, Var(Bt) = 2βBB0t .
In this case, conditioning on At survival has no effect as At and Bt are independent
processes. As for the number of biomarker molecules, from the functions CA(y, t)











In general, the expression for the latter mean would be the same forBt modelled as
a constant population or as a critical branching birth-death process. Furthermore,
in our setup such expectation does not depend on t as we start the process CBt
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The variance of Ct, and expressions for its first moments conditional on At survival
can be obtained as well from equation (C.7), but they are too cumbersome to be
reported here.
C.2.4 Sampling scheme
Here we derive the exact probability distribution for the number of biomarker
molecules present in a blood sample of a given volume at time t. To this end, let
us first assume that at t there is a fixed number Ct = n of biomarker molecules
uniformly distributed over a total volume Vtot of plasma. If we sample from it
a volume Vs, each molecule is in the sample independently of the others with
probability p = Vs
Vtot
. Hence, the total number Xt of biomarker molecules present
in the sample is binomially distributed with parameters n and p












The total number of biomarker molecules present in the plasma then follows by
averaging over all the possible values of Ct
P(Xt = k) =
∞∑
n=k
P(Ct = n)P(Xt = k | Ct = n) . (C.9)
The second term in the sum above is simply given by equation (C.8). As we
noticed in the derivation of our asymptotic results, if Ct follows a Poisson distri-
bution, then thanks to the thinning property Xt follows a Poisson distribution as
well. The expected value and variance of Xt in terms of Ct are given by
E[Xt] = pE[Ct] , Var(Xt) = p(1− p)E[Ct] + p2 Var(Ct) .




Xt = k | ΩAt
)
=




Here, of the two terms at the numerator, the first one coincides with equa-
tion (C.9), while the second one can be expanded as
P(Xt = k,At = 0) =
∞∑
n=k




P(Xt = k | Ct = n)P(At = 0 | Ct = n)P(Ct = n) .
The second equality follows from the fact that X and At are conditionally inde-
pendent given Ct. Equation (C.10) thus becomes
P(Xt = k | Ωt) =
∑∞









P(Xt = k | Ct = n)P(Ct = n | ΩAt ) .
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